1
|
Alixandre RD, Lima PAM, Almeida TFR, Oliveira JS, Pereira MB, Alixandre FT, Jacomino GRL, Dias RS, Alexandre RS, Ferreira A, Passos RR, Lopes JC. Potential of coffee straw biochal as a substrate conditioner in seed lettuce and sorghum germination and vigority. BRAZ J BIOL 2024; 83:e277437. [PMID: 38422256 DOI: 10.1590/1519-6984.277437] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2023] [Accepted: 10/17/2023] [Indexed: 03/02/2024] Open
Abstract
The use of residues from coffee production to obtain biochar is a sustainable approach, which aims to minimize the environmental impact of these materials. In this study, the effect of adding coffee straw biochar on the physiological quality of lettuce and sorghum seeds was investigated. Thus, the objective of this work was to study the effect of adding different concentrations of coffee biochar in the substrate composition on the physiological quality of lettuce (Lactuca sativa) and sorghum (Sorghum bicolor) seeds. The experimental design used was completely randomized, with five concentrations of biochar (0; 7.5; 15; 30 and 60%), conducted with four replications of 25 seeds. The use of biochar in the concentrations studied does not provide an increase in the average germination percentage and vigor of lettuce and sorghum seeds. The increase in the concentration of biochar caused less seed vigor, suggesting a toxic effect. For seed germination, there was no significant difference between lettuce and sorghum species, regardless of treatment. For the germination speed index, sorghum seeds have higher means, except for the treatment with the addition of 15% coffee straw biochar. Lettuce seeds have higher shoot length averages, except for treatment with 100% commercial substrate. The sorghum seeds have higher mean root length and dry mass than lettuce, regardless of the treatment.
Collapse
Affiliation(s)
- R D Alixandre
- Universidade Federal do Espírito Santo - UFES, Programa de Pós-graduação em Agronomia, Alegre, ES, Brasil
| | - P A M Lima
- Universidade Federal do Espírito Santo - UFES, Programa de Pós-graduação em Agronomia, Alegre, ES, Brasil
| | - T F R Almeida
- Universidade Federal do Espírito Santo - UFES, Programa de Pós-graduação em Agronomia, Alegre, ES, Brasil
| | - J S Oliveira
- Universidade Federal do Espírito Santo - UFES, Programa de Pós-graduação em Genética e Melhoramento, Alegre, ES, Brasil
| | - M B Pereira
- Universidade Federal do Espírito Santo - UFES, Programa de Pós-graduação em Agronomia, Alegre, ES, Brasil
| | - F T Alixandre
- Universidade Federal do Espírito Santo - UFES, Programa de Pós-graduação em Genética e Melhoramento, Alegre, ES, Brasil
| | - G R L Jacomino
- Universidade Federal do Espírito Santo - UFES, Programa de Pós-graduação em Genética e Melhoramento, Alegre, ES, Brasil
| | - R S Dias
- Universidade Federal do Espírito Santo - UFES, Programa de Pós-graduação em Genética e Melhoramento, Alegre, ES, Brasil
| | - R S Alexandre
- Universidade Federal do Espírito Santo - UFES, Programa de Pós-graduação em Genética e Melhoramento, Alegre, ES, Brasil
| | - A Ferreira
- Universidade Federal do Espírito Santo - UFES, Programa de Pós-graduação em Agronomia, Alegre, ES, Brasil
| | - R R Passos
- Universidade Federal do Espírito Santo - UFES, Programa de Pós-graduação em Agronomia, Alegre, ES, Brasil
| | - J C Lopes
- Universidade Federal do Espírito Santo - UFES, Programa de Pós-graduação em Agronomia, Alegre, ES, Brasil
| |
Collapse
|
2
|
Scott F, Smet ME, Elhindi J, Mogra R, Sunderland L, Ferreira A, Menezes M, Meagher S, McLennan A. Late first-trimester ultrasound findings can alter management after high-risk NIPT result. Ultrasound Obstet Gynecol 2023; 62:497-503. [PMID: 37247395 DOI: 10.1002/uog.26272] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/12/2023] [Revised: 05/14/2023] [Accepted: 05/17/2023] [Indexed: 05/31/2023]
Abstract
OBJECTIVE To evaluate the impact of detailed late first-trimester ultrasound (LFTU) on the positive predictive value (PPV) of a high-risk non-invasive prenatal test (NIPT) result for various chromosomal abnormalities. METHODS This was a retrospective study of all cases undergoing invasive prenatal testing from three tertiary providers of obstetric ultrasound over 4 years, each using NIPT as a first-line screening test. Data were collected from pre-NIPT ultrasound, NIPT, LFTU, placental serology and later ultrasound examinations. Prenatal testing for chromosomal abnormalities was performed by microarray, initially using array comparative genomic hybridization and then single nucleotide polymorphism (SNP) array for the last 2 years. Uniparental disomy testing was performed by SNP array during all 4 years. The majority of NIPT tests were analyzed using the Illumina platform, initially confined to the assessment of the common autosomal trisomies, sex chromosome aneuploidies and rare autosomal trisomies (RAT), then extending to genome-wide analysis for the last 2 years. RESULTS Amniocentesis or chorionic villus sampling (CVS) was performed on 2657 patients, 1352 (51%) of whom had undergone prior NIPT, with 612 (45%) of these returning a high-risk result and meeting the inclusion criteria for the study. LFTU findings significantly affected the PPV of the NIPT result for trisomies 13 (T13), 18 (T18) and 21 (T21), monosomy X (MX) and RAT but not for the other sex chromosomal abnormalities or segmental imbalances (> 7 Mb). Abnormal LFTU increased the PPV close to 100% for T13, T18, T21, MX and RAT. The magnitude of the change in PPV was highest for the most severe chromosomal abnormalities. When LFTU was normal, the incidence of confined placental mosaicism (CPM) was highest in those with a high-risk NIPT result for T13, followed by T18 and T21. After normal LFTU, the PPV for T21, T18, T13 and MX decreased to 68%, 57%, 5% and 25%, respectively. CONCLUSIONS LFTU after a high-risk NIPT result can alter the PPV for many chromosomal abnormalities, assisting counseling regarding invasive prenatal testing and pregnancy management. The high PPVs of NIPT for T21 and T18 are not sufficiently modified by normal LFTU findings to alter management. These at-risk patients should be offered CVS for earlier diagnosis, particularly given the low rate of CPM associated with these aneuploidies. Patients with a high-risk NIPT result for T13 and normal LFTU findings often wait for amniocentesis or avoid invasive testing altogether given the low PPV and higher rate of CPM in this context. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
Collapse
Affiliation(s)
- F Scott
- Sydney Ultrasound for Women, Sydney, Australia
- School of Women's and Children's Health, University of New South Wales, Sydney, Australia
| | - M-E Smet
- Sydney Ultrasound for Women, Sydney, Australia
- Maternal-Fetal Medicine Department, Westmead Hospital, Sydney, Australia
| | - J Elhindi
- Maternal-Fetal Medicine Department, Westmead Hospital, Sydney, Australia
| | - R Mogra
- Sydney Ultrasound for Women, Sydney, Australia
- Department of Obstetrics and Gynaecology, Royal Prince Alfred Hospital, Sydney, Australia
| | - L Sunderland
- Department of Obstetrics and Gynaecology, Royal Prince Alfred Hospital, Sydney, Australia
| | - A Ferreira
- Sydney Ultrasound for Women, Sydney, Australia
- School of Women's and Children's Health, University of New South Wales, Sydney, Australia
| | - M Menezes
- Monash Ultrasound for Women, Melbourne, Australia
| | - S Meagher
- Monash Ultrasound for Women, Melbourne, Australia
| | - A McLennan
- Sydney Ultrasound for Women, Sydney, Australia
- School of Women's and Children's Health, University of Sydney, Sydney, Australia
| |
Collapse
|
3
|
Garzon JL, Ferreira Ó, Reis MT, Ferreira A, Fortes CJEM, Zózimo AC. Conceptual and quantitative categorization of wave-induced flooding impacts for pedestrians and assets in urban beaches. Sci Rep 2023; 13:7251. [PMID: 37142611 PMCID: PMC10160089 DOI: 10.1038/s41598-023-32175-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2022] [Accepted: 03/23/2023] [Indexed: 05/06/2023] Open
Abstract
Beaches combined with sloping structures are frequently the first element of defense to protect urban areas from the impact of extreme coastal flooding events. However, these structures are rarely designed for null wave overtopping discharges, accepting that waves can pass above the crest and threat exposed elements in hinterland areas, such as pedestrians, urban elements and buildings, and vehicles. To reduce risks, Early Warning Systems (EWSs) can be used to anticipate and minimize the impacts of flooding episodes on those elements. A key aspect of these systems is the definition of non-admissible discharge levels that trigger significant impacts. However, large discrepancies in defining these discharge levels and the associated impacts are found among the existing methods to assess floodings. Due to the lack of standardization, a new conceptual and quantitative four-level (from no-impact to high-impact) categorization of flood warnings (EW-Coast) is proposed. EW-Coast integrates and unifies previous methods and builds on them by incorporating field-based information. Thus, the new categorization successfully predicted the impact level on 70%, 82%, and 85% of the overtopping episodes affecting pedestrians, urban elements and buildings, and vehicles, respectively. This demonstrates its suitability to support EWSs in areas vulnerable to wave-induced flooding.
Collapse
Affiliation(s)
- J L Garzon
- CIMA, Centre of Marine and Environmental Research\ARNET - Infrastructure Network in Aquatic Research, University of Algarve, Campus de Gambelas, 8000-139, Faro, Portugal.
| | - Ó Ferreira
- CIMA, Centre of Marine and Environmental Research\ARNET - Infrastructure Network in Aquatic Research, University of Algarve, Campus de Gambelas, 8000-139, Faro, Portugal
| | - M T Reis
- Hydraulics and Environment Department, National Laboratory for Civil Engineering, Av. Do Brasil, 101, 1700-066, Lisboa, Portugal
| | - A Ferreira
- Hydraulics and Environment Department, National Laboratory for Civil Engineering, Av. Do Brasil, 101, 1700-066, Lisboa, Portugal
| | - C J E M Fortes
- Hydraulics and Environment Department, National Laboratory for Civil Engineering, Av. Do Brasil, 101, 1700-066, Lisboa, Portugal
| | - A C Zózimo
- Hydraulics and Environment Department, National Laboratory for Civil Engineering, Av. Do Brasil, 101, 1700-066, Lisboa, Portugal
| |
Collapse
|
4
|
de Pinho IS, Barroso T, Trabulo C, Campoa E, Patel V, Gonçalves L, Araújo J, Monteiro C, Ferreira A, Machado B, Dâmaso S, Luz P, de Sousa RT, Costa L. P159 Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio are not predictive of Pathologic Complete Response to Neoadjuvant Chemotherapy in Triple-negative Breast Cancer. Breast 2023. [DOI: 10.1016/s0960-9776(23)00276-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/16/2023] Open
|
5
|
Almeida F, Rocha F, Teixeira J, Ferreira A. Hydrodynamics and gas-liquid mass transfer in an oscillatory flow reactor: influence of liquid properties. Chem Eng Res Des 2023. [DOI: 10.1016/j.cherd.2023.03.030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/22/2023]
|
6
|
Vieira E Brito D, Pedrosa M, Pereira J, Ferreira A, Pereira M, Godinho R, Pereira B, Peralta P, Conceição P, Reis M, Rabaça C. Prospective trial of Cefixime vs. Fosfomycin in prostate biopsy. Eur Urol 2023. [DOI: 10.1016/s0302-2838(23)00184-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
|
7
|
Yailian AL, Rerbal D, Charniguet D, Ferreira A, Dumes J, Debord-Peguet S, Paillet C. Renfort en réanimation pendant l’épidémie à Covid-19 : formation flash des infirmiers par les pharmaciens. Le Pharmacien Clinicien 2022. [PMCID: PMC9748204 DOI: 10.1016/j.phacli.2022.10.620] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
|
8
|
Maltes S, Lima R, Santos RR, Freitas P, Lopes PMD, Marta L, Guerreiro S, Abecasis J, Ferreira A, Ribeiras R, Andrade MJ. A preliminary analysis regarding functional mitral regurgitation grading with echocardiography and CMR: in search of similarities and resolving discordances. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.1542] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Functional mitral regurgitation (fMR) severity grading by 2D transthoracic echocardiography (TTE) can be a complex task, especially in patients where PISA assumptions are not met (eg. non-circular orifice or multiple jets). Cardiac magnetic resonance (CMR) can provide further insight on the hemodynamic burden of fMR by accurately determining mitral regurgitant fraction (RegFrac). Our goal was to investigate the concordance and disagreement between the two modalities in assessing fMR.
Methodology
Single-center prospective study of fMR patients performing same-day TTE and CMR from Feb to Dec 2021. MR severity was classified according to 2020 ACC consensus: grade I (mild; EROA <0.20 cm2), grade II (moderate; EROA 0.20–0.29 cm2), grade III (moderate-to-severe; EROA 0.30–0.39 cm2) and grade IV (severe; EROA ≥0.40 cm2). MR assessment by CMR was determined through regurgitant volume (RVol) and RegFrac quantification. A RegFrac ≥35% (recently shown as the best cut-off for prognostication) was considered hemodynamically significant.
Results
A total of 36 patients were included (age 65±14y; 74% male; left ventricle [LV] ejection fraction by TTE and CMR 35±13% and 34±11%, respectively). Mean RVol and EROA by TTE were 28±11mL and 0.18±0.8 cm2. Mean RVol and Regfrac by CMR were 20±13 mL and 25±12%, respectively. A moderate correlation between RVol by TTE and CMR was found (Pearson's R 0.58, p=0.001). According to TTE, there were 20 patients (56%) with grade I fMR, 12 patients (33%) with grade II fMR and 4 patients (11%) with grade III fMR. All patients considered to have mild (grade I) fMR by TTE had a RegFrac <35% at CMR. However, amongst those with moderate and moderate-to-severe (grades II and III) fMR, there were 8 patients (50%) with hemodynamic significant fMR (RegFrac ≥35%) at CMR – see Figure 1. Those with RegFrac ≥35% by CMR had higher indexed LV diastolic (165±24 vs 139±48 mL/m2) and systolic (116±31 vs 95±48 mL/m2) volumes and higher pulmonary artery systolic pressures (48±14 vs 41±16 mmHg) when compared with patients whose RegFrac was <35%, even though statistically significance was not reached.
Conclusion
Using the criterion of RegFrac ≥35%, CMR re-classifies (half for each side) the patients with moderate and moderate-to-severe regurgitations by TTE. Recognizing, overcoming and resolving the disagreements between the techniques is the way forward to reach excellence.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- S Maltes
- Hospital Santa Cruz , Lisbon , Portugal
| | - R Lima
- Hospital Santa Cruz , Lisbon , Portugal
| | | | - P Freitas
- Hospital Santa Cruz , Lisbon , Portugal
| | | | - L Marta
- Hospital Santa Cruz , Lisbon , Portugal
| | | | | | | | | | | |
Collapse
|
9
|
Paiva M, Gomes D, Freitas P, Santos R, Presume J, Lopes P, Matos D, Guerreiro S, Santos A, Saraiva S, Mendes M, Ferreira A. Potential impact of replacing SCORE with SCORE-2 on risk classification and statin eligibility – a coronary calcium score correlation study. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.2257] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Recently, the European Society of Cardiology issued new algorithms to estimate the 10-year risk of atherosclerotic cardiovascular disease (ASCVD), along with new age-specific thresholds to classify individuals as low-to-moderate, high, or very-high risk.
The aim of this study was to compare the latest SCORE-2 model with the older SCORE (Systematic COronary Risk Evaluation) in their ability to identify individuals with high coronary artery calcium score (CACS), and assess the relationship between potential eligibility for statin therapy and CACS.
Methods
Individuals 40–69 years old without diabetes or known ASCVD were identified in a single center registry of patients undergoing CACS and coronary CT angiography for suspected coronary artery disease. SCORE and SCORE-2 were calculated and used with each patient's untreated LDL-C values to assess eligibility for statin therapy. High CACS was defined as an Agatston score ≥100.
Results
A total of 389 pts (46% men, mean age 58±8 years) were included, of which 15% (n=60) were active smokers. The mean systolic blood pressure and untreated LDL-C values were 136±17 mmHg and 155±65 mg/dL, respectively.
The proportion of patients classified as low-to-moderate risk, high risk, and very high risk was 93%, 6% and 1% using the SCORE algorithm, and 42%, 44%, and 14% using SCORE-2, respectively. Overall, 218 patients (56%) would have their risk category revised upwards, while no patients would be downgraded.
The median CACS was 5 (IQR 0–71 AU), with 166 patients (43%) having CACS = 0, and 81 (21%) presenting CACS values ≥100.
SCORE and SCORE-2 showed similar discriminative power to identify patients with CACS ≥100 (C-statistic 0.77, 95% CI 0.71–0.82, vs. 0.75, 95% CI 0.69–0.80, P=0.109 for comparison]. The up-reclassification of risk conveyed by SCORE-2 affected patients across all categories of CACS (Fig. 1).
The proportion of patients in whom statin therapy would generally be indicated was higher with the SCORE-2 criteria vs. the SCORE algorithm (61% vs. 29%, respectively, p<0.001). The broadening of potential indication for statin therapy spanned all categories of CACS, including patients with CACS = 0 (Fig. 2).
Conclusion
Even though the discriminative power of SCORE-2 is similar to the older SCORE, the introduction of age-specific thresholds results in the up-reclassification of risk in roughly half of the patients. The application of SCORE-2 will broaden statin eligibility overall, not only in patients with high atherosclerotic burden, but also in those with CACS = 0. These findings support the use of risk modifiers in selected patients to improve the effectiveness of statin therapy.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- M Paiva
- Centro Hospitalar de Lisboa Ocidental , Lisbon , Portugal
| | - D Gomes
- Centro Hospitalar de Lisboa Ocidental , Lisbon , Portugal
| | - P Freitas
- Centro Hospitalar de Lisboa Ocidental , Lisbon , Portugal
| | - R Santos
- Centro Hospitalar de Lisboa Ocidental , Lisbon , Portugal
| | - J Presume
- Centro Hospitalar de Lisboa Ocidental , Lisbon , Portugal
| | - P Lopes
- Centro Hospitalar de Lisboa Ocidental , Lisbon , Portugal
| | - D Matos
- Centro Hospitalar de Lisboa Ocidental , Lisbon , Portugal
| | - S Guerreiro
- Centro Hospitalar de Lisboa Ocidental , Lisbon , Portugal
| | - A Santos
- Centro Hospitalar de Lisboa Ocidental , Lisbon , Portugal
| | - S Saraiva
- Centro Hospitalar de Lisboa Ocidental , Lisbon , Portugal
| | - M Mendes
- Centro Hospitalar de Lisboa Ocidental , Lisbon , Portugal
| | - A Ferreira
- Centro Hospitalar de Lisboa Ocidental , Lisbon , Portugal
| |
Collapse
|
10
|
R Santos R, Abecasis J, Maltes S, Mendes GS, Guerreiro S, Padrao C, Freitas P, Ferreira A, Ribeiras R, Andrade MJ, Cardim N, Gil V, Neves JP, Ramos S, Mendes M. Relative apical sparing in severe aortic stenosis: does it mean concomitant amyloid cardiomyopathy? Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.137] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
Relative apical sparing (RAS) of left ventricular (LV) longitudinal strain (LS) is a red flag marker for the suspicion of amyloid cardiomyopathy. However, it has also been described in patients with severe aortic stenosis (AS).
Aim
To assess the prevalence of RAS in patients with severe symptomatic AS referred for surgical aortic valve replacement (AVR), to evaluate its clinical significance and assess its presence after surgery.
Methods
We prospectively studied 135 consecutive patients (age: 73 y [IQR 68–77 y], 49% men) with severe symptomatic AS – mean transaortic pressure gradient (AVmean): 60.9±17.7 mmHg; mean aortic valve area: 0.7±0.2 cm2, referred for surgical AVR with no previous history of ischemic cardiomyopathy or other. Beyond 12 lead-ECG and transthoracic echocardiography (TTE), all patients underwent cardiac magnetic resonance (CMR) before surgery. RAS was defined by the ratio >1 of average LS at apical segments/sum of the average basal and mid LS at speckle tracking analysis. AVR with septal myocardial biopsy, for investigational purposes, was performed in 80 patients. AS severity indexes, LV remodeling and tissue characterization parameters were compared in both groups of patients, with and without RAS. LS deformation pattern was reassessed at 3–6 months after AVR.
Results
RAS was present in 24 patients (18%). In the whole cohort there were neither pseudoinfarct pattern or low voltage ECG criteria, nor infiltration suspicion from CMR (native T1 value 1053 ms [IQR 1025–1071 ms] for institutional reference values: 972–1070 ms; ECV 24% [IQR 21–27%]). None of the patients had amyloid deposition at histopathology. Overall, mean CMR LV ejection fraction (LVEF) was 59.6±10.5% and 98 patients (74%) had non-ischemic delayed enhancement, with a median fibrosis fraction of 4.1% [IQR 1.6–7.8%]. RAS cohort had a significantly higher AVmean gradient, relative wall thickness, maximum septal thickness, peak systolic dispersion, with lower global LS at TTE, as well as higher LV mass and lower LVEF at CMR. RAS group has also higher NT-proBNP ambulatory values (Table 1). Follow-up evaluation after AVR revealed RAS disappearance in 19 patients (79.2%).
Conclusions
RAS occurs in almost one-fifth of the patients in this cohort despite the absence of signs of myocardial infiltration. This deformation pattern elapses with worse indexes of LV remodeling consistent with a more advanced stage of the disease, being reversible after AVR, which stands for the absence of concomitant myocardial infiltration.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
| | | | - S Maltes
- Hospital Santa Cruz , Lisbon , Portugal
| | | | | | - C Padrao
- Hospital Santa Cruz , Lisbon , Portugal
| | - P Freitas
- Hospital Santa Cruz , Lisbon , Portugal
| | | | | | | | - N Cardim
- Nova Medical School , Lisbon , Portugal
| | - V Gil
- Hospital da Luz, SA , Lisbon , Portugal
| | - J P Neves
- Hospital Santa Cruz , Lisbon , Portugal
| | - S Ramos
- Hospital Santa Cruz , Lisbon , Portugal
| | - M Mendes
- Hospital Santa Cruz , Lisbon , Portugal
| |
Collapse
|
11
|
Lopes P, Albuquerque F, Freitas P, Goncalves PA, Presume J, Guerreiro S, Abecasis J, Santos AC, Saraiva C, Mendes M, Marques H, Ferreira A. Influence of age on the diagnostic value of coronary artery calcium score for ruling out coronary stenosis in symptomatic patients. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.189] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
The 2021 Guideline for the Evaluation of Chest Pain supports the use of coronary artery calcium (CAC) score as a reasonable first-line test to identify patients with a low likelihood of obstructive coronary artery disease (CAD) who may not require additional testing (class IIa, LOE B). However, a recent study from a large cohort of Northern European patients raised concerns about the added diagnostic value of CAC=0 in younger patients. The aim of this study was to assess the influence of age on the value of CAC=0 in symptomatic patients undergoing coronary computed tomography angiography (CCTA).
Methods
We conducted a two-center cross-sectional study assessing symptomatic patients with suspected CAD who underwent CAC score and CCTA. Key exclusion criteria were age <30 years, known CAD, suspected acute coronary syndrome, or symptoms other than chest pain or dyspnea. Pretest probability of obstructive CAD was calculated based on age, sex and symptom typicality, according to the guideline-recommended method. Obstructive CAD was defined as any luminal stenosis ≥50% on CCTA. The diagnostic likelihood ratios and negative predictive values (NPV) were used to assess the diagnostic value of a CAC score of 0 to rule out obstructive CAD.
Results
A total of 2043 patients (mean age 60±11 years, 60% women) of whom 990 (48.5%) had a CAC score of 0 were included in the analysis. Symptom characteristics were: 38% non-anginal chest pain, 30% atypical angina, 19% dyspnea, and 13% typical chest pain. Overall, the prevalence of obstructive CAD was 12.8% (n=262). Pretest probability of obstructive CAD increased progressively with age, from 6.0% in patients young than 50 years to 20.7% in those 70 years or older. Contrariwise, the prevalence of patients with a CAC score = 0 decreased from 77% in patients younger than 50 years, to 26% in those who where 70 years or older.
The added diagnostic value of a CAC score = 0 was lower in younger patients, with negative likelihood ratios ranging from 0.36 (64% decrease in the likelihood of CAD) in patients younger than 50 years, to 0.09 and 0.10 (∼90% decrease in the likelihood of CAD) in those aged 60–69 years and 70 years or older, respectively – Figure 1.
Despite this, the prevalence of obstructive CAD among patients with a CAC score = 0 was low across all age groups: 2.4% (i.e., NPV = 97.6%) in those younger than 50 years, 3.0% (NPV = 97.0%) among those aged 50–59 years, 1.5% (NPV = 98.5%) in patients between 60 and 69 years, and 2.0% (NPV = 98.0%) among those 70 years or older.
Conclusions
In a cohort of symptomatic patients undergoing CCTA for suspected CAD, the added diagnostic value of a CAC score of zero decreases significantly at younger ages. However, this “diminishing return” of CAC in younger patients if offset by their lower pretest probabilities, yielding high negative predictive values independently of age.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- P Lopes
- Hospital Santa Cruz , Carnaxide , Portugal
| | | | - P Freitas
- Hospital Santa Cruz , Carnaxide , Portugal
| | - P A Goncalves
- UNICA – Cardiovascular CT and MR Unit, Hospital da Luz , Lisbon , Portugal
| | - J Presume
- Hospital Santa Cruz , Carnaxide , Portugal
| | | | - J Abecasis
- Hospital Santa Cruz , Carnaxide , Portugal
| | - A C Santos
- Hospital Santa Cruz , Carnaxide , Portugal
| | - C Saraiva
- Hospital Santa Cruz , Carnaxide , Portugal
| | - M Mendes
- Hospital Santa Cruz , Carnaxide , Portugal
| | - H Marques
- UNICA – Cardiovascular CT and MR Unit, Hospital da Luz , Lisbon , Portugal
| | - A Ferreira
- Hospital Santa Cruz , Carnaxide , Portugal
| |
Collapse
|
12
|
Maltes S, Abecasis J, Pinto DG, Santos RR, Oliveira L, Mendes GS, Guerreiro S, Lima T, Freitas P, Ferreira A, Ramos S, Felix A, Cardim N, Gil VM, Mendes M. Histology-verified myocardial fibrosis and quantification in severe AS patients: correlation with non-invasive LV myocardial tissue assessment. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.2996] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Myocardial fibrosis (MF) is a common finding and a potential adverse prognostic marker in several cardiac diseases, including in severe aortic stenosis (AS). While histological analysis obtained through endomyocardial biopsy remains the gold-standard for MF assessment, non-invasive cardiac imaging may offer surrogate biomarkers for fibrosis. We tried to assess the correlation between MF quantification at histopathology and cardiac magnetic resonance (CMR)-derived tissue characterization data in patients with severe AS.
Methodology
Single-center prospective cohort enrolling 71 patients with severe symptomatic high-gradient AS undergoing surgical aortic valve replacement (SAVR) (mean age 71±9 years; 49% male, mean valvular transaortic gradient 60±20 mmHg; mean left ventricle [LV] ejection fraction 58±9%). Those with past history of myocardial infarction or cardiomyopathy were excluded. All patients underwent pre-operative CMR study with LV tissue characterization and quantification. Normal T1 mapping value was defined as >1021ms as per center protocol. Myocardial tissue was obtained during SAVR either through myocardial biopsy at basal LV septum or harvested from surgical myectomy specimens. Masson's trichrome stain was used for collagen/fibrosis assessment. Automatic quantification was obtained at QuPathTM digital pathology software after applying a dedicated artificial intelligence algorithm on ultra-high-resolution digital slide scanning images.
Results
Histology-confirmed MF was observed in all patients (median percentage of fibrotic myocardial tissue 15% [IQR 9–22%]). Median global T1 mapping and extracellular volume (ECV) percentage was 1048ms (IQR 1027–1078) and 24% (IQR 20–30%), respectively. Late gadolinium enhancement (LGE) with a non-ischemic pattern was present in 42 patients (59%) with a median LGE mass of 5.8g [IQR 1.0–10.2]; median percentage of 3.7% [IQR 0.6–10.4]. While neither T1 mapping (global or basal LV septum), ECV nor LGE had any significant correlation with histology-confirmed MF (Figure 1) the vast majority had significantly elevated global and basal LV septum T1 mapping – 81% and 92%, respectively.
Conclusion
In this single-center prospective study, microscopic MF was present in all patients with severe symptomatic high-gradient AS, was accompanied by elevated T1 mapping values but no correlation was found between myocardial fibrosis at histopathology analysis and CMR-derived LV tissue characterization parameters. This may not only stem from sampling (single point biopsy vs. whole myocardial tissue assessment) but also from distinct evaluation of different types of fibrosis by different methods.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- S Maltes
- Hospital Santa Cruz , Lisbon , Portugal
| | | | - D G Pinto
- Hospital Santa Cruz , Lisbon , Portugal
| | | | | | | | | | - T Lima
- Hospital Santa Cruz , Lisbon , Portugal
| | - P Freitas
- Hospital Santa Cruz , Lisbon , Portugal
| | | | - S Ramos
- Hospital Santa Cruz , Lisbon , Portugal
| | - A Felix
- Portuguese Institute of Oncology Lisbon , Lisbon , Portugal
| | - N Cardim
- Hospital da Luz, SA , Lisbon , Portugal
| | - V M Gil
- Hospital da Luz, SA , Lisbon , Portugal
| | - M Mendes
- Hospital Santa Cruz , Lisbon , Portugal
| |
Collapse
|
13
|
Lopes P, Cunha G, Freitas P, Rocha B, Abecasis J, Carmo J, Guerreiro S, Galvao Santos P, Moscoso Costa F, Carmo P, Cavaco D, Morgado F, Mendes M, Adragao P, Ferreira A. The peri-infarct gray zone of myocardial fibrosis is a better predictor of ventricular arrhythmias than dense core fibrosis in patients with previous myocardial infarction. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.290] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Current sudden cardiac death (SCD) risk stratification relies heavily on left ventricular ejection fraction (LVEF), but markers to refine risk assessment are needed. Dense core fibrosis (DCF) and peri-infarct “gray zone” of myocardial fibrosis (GZF) on late gadolinium enhancement (LGE) cardiac magnetic resonance (CMR) have been proposed as potential arrhythmogenic substrates. The aim of our study was to determine whether DCF and GZF could predict the occurrence of ventricular arrhythmias in patients with previous myocardial infarction.
Methods
We performed a single centre retrospective study enrolling consecutive patients with previous myocardial infarction undergoing CMR before implantable cardioverter-defibrillator (ICD) implantation. Areas of LGE were subdivided into “core” DCF and “peri-infarct” GZF zones based on signal intensity (>5 SD, and 2–5 SD above the mean of reference myocardium, respectively).
The primary endpoint was a composite of sudden arrhythmic death, appropriate ICD shock, ventricular fibrillation (VF), or sustained ventricular tachycardia (VT) as detected by the device.
Results
A total of 88 patients (median age 61 years [IQR 54–73], 84% male, median LVEF 30% [IQR 23–36%], 14% secondary prevention) were included. During a median follow-up of 23 months [IQR 9–38], 13 patients reached the primary endpoint (10 appropriate ICD shock, 2 sustained VT or VF, and 1 sudden arrhythmic death). Patients who attained the primary endpoint had similar DCF (30.4±14.7 g vs. 28.0±15.3 g; P=0.601) but a greater amount of GZF (18.1±9.6 g vs. 11.9±6.7 g; P=0.005). On univariate analysis, GZF was associated with the composite endpoint (HR: 1.09 per gram; 95% CI: 1.02–1.15; P=0.006), whereas DCF was not (HR: 1.01 per gram; 95% CI: 0.98–1.05; P=0.571). After adjustment for LVEF, GZF remained independently associated with the primary endpoint (adjusted HR: 1.06 per gram; 95% CI: 1.01–1.12; P=0.035). Decision tree analysis identified 11.9g of GZF as the best cut-off to predict life-threatening arrhythmic events. The primary endpoint occurred in 11 out of the 35 patients (31.4%) with GZF ≥11.9 g, but in only 2 of the 53 patients (3.8%) with GZF <11.9 g – Figure 1.
Conclusions
The extent of peri-infarct GZF seems to be a better predictor of ventricular arrhythmias than DCF. This parameter may be useful to identify a subgroup of patients with previous myocardial infarction at increased risk of life-threatening arrhythmic events.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- P Lopes
- Hospital Santa Cruz , Carnaxide , Portugal
| | - G Cunha
- Hospital Santa Cruz , Carnaxide , Portugal
| | - P Freitas
- Hospital Santa Cruz , Carnaxide , Portugal
| | - B Rocha
- Hospital Santa Cruz , Carnaxide , Portugal
| | - J Abecasis
- Hospital Santa Cruz , Carnaxide , Portugal
| | - J Carmo
- Hospital Santa Cruz , Carnaxide , Portugal
| | | | | | | | - P Carmo
- Hospital Santa Cruz , Carnaxide , Portugal
| | - D Cavaco
- Hospital Santa Cruz , Carnaxide , Portugal
| | - F Morgado
- Hospital Santa Cruz , Carnaxide , Portugal
| | - M Mendes
- Hospital Santa Cruz , Carnaxide , Portugal
| | - P Adragao
- Hospital Santa Cruz , Carnaxide , Portugal
| | - A Ferreira
- Hospital Santa Cruz , Carnaxide , Portugal
| |
Collapse
|
14
|
Paiva M, Gomes D, Freitas P, Presume P, Santos R, Lopes P, Matos D, Guerreiro S, Abecasis J, Santos A, Saraiva C, Mendes M, Ferreira A. Use of coronary calcium score to refine the cardiovascular risk classification of the new SCORE2 and SCORE2-OP algorithms in patients undergoing coronary CT angiography. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.194] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Introduction
Recently, the European Society of Cardiology issued new algorithms (SCORE-2 and SCORE2-OP) to estimate the 10-year risk of atherosclerotic cardiovascular disease (ASCVD). CACS has been shown to reclassify a significant proportion of patients when applied on top of several scores, but data on its use with these new algorithms are lacking.
The aim of this study was to assess the risk reassignment that can be attained by using CACS as a risk modifier of the SCORE-2 / SCORE2-OP classification, in patients referred for coronary CT angiography (CCTA).
Methods
Individuals without diabetes or known ASCVD were included in a single center registry of patients undergoing CCTA for suspected coronary artery disease (CAD). The 10-year risk of cardiovascular disease was calculated for each patient using SCORE-2 (ages 40–69) or SCORE2-OP (ages 70–89), and categorised as low-to-moderate, high, or very-high risk, according to guideline-recommended age-specific thresholds. CACS was considered to reclassify risk one level downward if = 0 in high or very-high risk patients, and reclassify risk upward if >100 (or >75th percentile) in those with low-to-moderate risk, or >1000 in those with high-risk.
Results
A total of 529 patients (43% men, mean age 63±10 years) were included, of which 13% (n=69) were active smokers. The mean systolic blood pressure and non-HDL-C values were 137±18 mmHg and 140±37 mg/dL, respectively.
A total of 47 patients (9%) had obstructive CAD on CCTA, classifying them as very-high risk. In the remainder 482 patients without obstructive CAD, the median CACS was 8 (IQR 0–80 AU), with 194 patients (40%) having CACS = 0, and 111 (23%) presenting CACS values ≥100.
The proportion of patients classified as low-to-moderate risk, high risk, and very high risk was 36%, 46% and 19% using the SCORE-2 / SCORE2-OP algorithm.
Using CACS would reclassify 150 patients (31%): 107 patients (22%) downward, and 43 patients (9%) upward. The extent of risk reclassification conveyed by CACS was 33% in patients assessed with SCORE-2, and 25% with SCORE-2 OP (p=0.082). Overall, most of the risk reassignment (42%, n=93) would occur in patients originally classified as high-risk – Fig. 1.
At the time of testing, 32% (n=61) of patients with CACS = 0 were being treated with statins, whereas 52% (n=58) of those with CACS ≥100 were not.
Conclusion
Even when the most recent SCORE-2 / SCORE-2 OP algorithms are used, risk refinement with CACS leads to the reclassification of nearly one third of the patients undergoing CCTA, mostly from downgrading risk. This opportunistic use of CACS may be employed to improve the allocation of primary prevention therapies.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- M Paiva
- Centro Hospitalar de Lisboa Ocidental , Lisbon , Portugal
| | - D Gomes
- Centro Hospitalar de Lisboa Ocidental , Lisbon , Portugal
| | - P Freitas
- Centro Hospitalar de Lisboa Ocidental , Lisbon , Portugal
| | - P Presume
- Centro Hospitalar de Lisboa Ocidental , Lisbon , Portugal
| | - R Santos
- Centro Hospitalar de Lisboa Ocidental , Lisbon , Portugal
| | - P Lopes
- Centro Hospitalar de Lisboa Ocidental , Lisbon , Portugal
| | - D Matos
- Centro Hospitalar de Lisboa Ocidental , Lisbon , Portugal
| | - S Guerreiro
- Centro Hospitalar de Lisboa Ocidental , Lisbon , Portugal
| | - J Abecasis
- Centro Hospitalar de Lisboa Ocidental , Lisbon , Portugal
| | - A Santos
- Centro Hospitalar de Lisboa Ocidental , Lisbon , Portugal
| | - C Saraiva
- Centro Hospitalar de Lisboa Ocidental , Lisbon , Portugal
| | - M Mendes
- Centro Hospitalar de Lisboa Ocidental , Lisbon , Portugal
| | - A Ferreira
- Centro Hospitalar de Lisboa Ocidental , Lisbon , Portugal
| |
Collapse
|
15
|
Lopes P, Albuquerque F, Goncalves PA, Presume J, Freitas P, Guerreiro S, Abecasis J, Santos AC, Saraiva C, Mendes M, Marques H, Ferreira A. Implications of the North American 2021 Chest Pain guidelines in the diagnostic approach to patients with stable chest pain and low pretest probability of obstructive coronary artery disease. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.188] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
The North American 2021 Chest Pain Guidelines recommend not testing stable patients with low pretest likelihood of obstructive coronary artery disease (CAD), defined as pretest probability <15% using contemporary models (Class I recommendation). In selected cases among this subset of patients, coronary artery calcium (CAC) score is considered a “reasonable first-line test” (Class IIa). Despite some supporting evidence, the clinical implications of a widespread adoption of these recommendations remain unclear.
The purpose of this study was to assess the results of three different testing strategies for patients with pretest probability <15%: A) defer testing; B) perform CAC score and withhold further testing if = 0, and proceed to coronary CT angiography (CCTA) if >0; C) perform CCTA in all.
Methods
We conducted a two-center cross-sectional study assessing symptomatic patients with suspected CAD who underwent CAC score and CCTA. Patients with known CAD, suspected acute coronary syndrome, or symptoms other than chest pain or dyspnea were excluded. Pretest probability of obstructive CAD was calculated based on age, sex and symptom typicality. Obstructive CAD was defined as any luminal stenosis ≥50% on CCTA.
Results
A total of 2259 patients were screened, of which 1385 (61.3%) had pretest probability <15% and were included in the analysis (mean age 57±11 years, 79% women). Symptom characteristics were: 48% non-anginal chest pain, 26% atypical angina, 21% dyspnea, and 5% typical chest pain. Overall, the prevalence of obstructive CAD was 10.3% (n=142). In the 786 patients (56.6%) with a CAC score of 0, 8.5% (n=67) had some degree of CAD [1.9% (n=15) obstructive, and 6.6% (n=52) nonobstructive]. Among those with CAC >0 (n=599), 21.2% (n=127) had obstructive CAD. The results that would be reached with each of the 3 diagnostic strategies are presented in Figure 1. The number of patients needed to scan with strategy B (CAC as gatekeeper) vs. A (no testing) to identify one patient with obstructive CAD was 11, whereas the number needed to scan with strategy C (CCTA for all) vs. strategy B was 91.
Conclusions
Not testing patients with suspected CAD and pretest likelihood <15% would lead to missing obstructive CAD in 1 out of 10 patients. Using CAC as a gatekeeper in this subgroup would decrease the use of CCTA by more than 50%, at the cost of missing obstructive CAD in 1 out of 100 patients. These findings may be used to inform decisions on testing, which will ultimately depend on how much diagnostic uncertainty and missed diagnoses patients and their physicians are willing to accept.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- P Lopes
- Hospital Santa Cruz , Carnaxide , Portugal
| | | | - P A Goncalves
- UNICA – Cardiovascular CT and MR Unit, Hospital da Luz , Lisbon , Portugal
| | - J Presume
- Hospital Santa Cruz , Carnaxide , Portugal
| | - P Freitas
- Hospital Santa Cruz , Carnaxide , Portugal
| | | | - J Abecasis
- Hospital Santa Cruz , Carnaxide , Portugal
| | - A C Santos
- Hospital Santa Cruz , Carnaxide , Portugal
| | - C Saraiva
- Hospital Santa Cruz , Carnaxide , Portugal
| | - M Mendes
- Hospital Santa Cruz , Carnaxide , Portugal
| | - H Marques
- UNICA – Cardiovascular CT and MR Unit, Hospital da Luz , Lisbon , Portugal
| | - A Ferreira
- Hospital Santa Cruz , Carnaxide , Portugal
| |
Collapse
|
16
|
R Santos R, Abecasis J, Maltes S, Mendes GS, Oliveira L, Horta E, Guerreiro S, Freitas P, Ferreira A, Ribeiras R, Andrade MJ, Cardim N, Gil V, Mendes M, Neves JP. Left ventricular remodeling in aortic stenosis patients referred for surgical aortic valve replacement. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.237] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Left ventricular (LV) hypertrophy is a common expected finding in aortic stenosis (AS) patients. Cardiac magnetic resonance (CMR) plays an important role as a non-invasive method for determining LV mass and volume, and to characterize the LV remodeling response in AS.
Aim
To assess the prevalence, to describe the patterns and evolution of LV remodeling (by CMR) in AS patients referred for surgical aortic valve replacement (AVR).
Methods
Single-center prospective cohort of 132 consecutive patients (73 years [68–77 years], 49% men] with severe AS: mean transaortic pressure gradient (AVmean): 61±1.5 mmHg; aortic valve area (AVA): 0.7±0.1 cm2, referred for surgical AVR, with no previous history of ischemic cardiomyopathy. Before surgery, all patients underwent electrocardiogram, complete transthoracic echocardiogram (TTE) and CMR for LV assessment and tissue characterization (mean LV indexed mass [LVMi]: 80.3±26.5 g/m2; mean end-diastolic LV indexed volume [LVEDVi]: 84.4±24.5 mL/m2 and median geometric remodeling ratio [M/V]: 0.95 g/mL [IQR 0. 81–1.08 g/mL]). Patterns of LV remodeling were investigated before and after AVR by CMR measurements of LVMi, LVEDVi and M/V. Besides normal LV ventricular structure, four other patterns were considered: concentric remodeling, concentric hypertrophy, eccentric hypertrophy, and adverse remodeling (Figure 1).
Results
Overall, 43% (n=58) of the patients had concentric hypertrophy, 30% (n=40) concentric remodeling, 22% (n=29) normal ventricular geometry, 4% (n=5) eccentric hypertrophy and in two patients we observed an adverse remodeling pattern. AVR was performed in 80 patients. At the 3rd to 6th month post-AVR assessment, LV remodeling changed to: normal ventricular geometry in 46%, concentric remodeling in 31%, concentric hypertrophy in 19%, eccentric hypertrophy in 3% and adverse remodeling in only one patient (Figure 1).
Conclusions
In this group of patients with severe aortic stenosis, concentric hypertrophy was not the sole pattern of LV remodeling and two out of every five still presented a normal ventricular geometry and mass as assessed by CMR. LV response was dynamic after AVR which stands for complex and multifactorial interaction in these group of patients despite similar valvular pathophysiology and therapeutic intervention.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
| | | | - S Maltes
- Hospital Santa Cruz , Lisbon , Portugal
| | | | - L Oliveira
- Hospital Divino Espirito Santo , Ponta Delgada , Portugal
| | - E Horta
- Hospital Santa Cruz , Lisbon , Portugal
| | | | - P Freitas
- Hospital Santa Cruz , Lisbon , Portugal
| | | | | | | | - N Cardim
- Nova Medical School , Lisbon , Portugal
| | - V Gil
- Hospital da Luz, SA , Lisbon , Portugal
| | - M Mendes
- Hospital Santa Cruz , Lisbon , Portugal
| | - J P Neves
- Hospital Santa Cruz , Lisbon , Portugal
| |
Collapse
|
17
|
R Santos R, Abecasis J, Maltes S, Mendes GS, Oliveira L, Horta E, Guerreiro S, Freitas P, Ferreira A, Ribeiras R, Andrade MJ, Cardim N, Gil V, Mendes M, Neves JP. Cardiac magnetic resonance patterns of left ventricular hypertrophy in aortic stenosis patients. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.1544] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
Left ventricular (LV) hypertrophy is a known compensatory mechanism to pressure overload in aortic stenosis (AS) patients. However, by cardiac magnetic resonance (CMR) different patterns of LV adaptation are seen in this group of patients.
Aim
To describe the patterns of LV adaptation (by CMR) and to analyze its structure and function indexes in AS patients referred for surgical aortic valve replacement (AVR).
Methods
We prospectively studied 134 consecutive patients (age: 73y [IQR 68–77y], 49% men) with severe symptomatic AS - mean transaortic pressure gradient (AVmean): 61±1.5 mmHg; mean aortic valve area: AVA): 0.7±0.1 cm2, referred for surgical AVR with no previous history of ischemic cardiomyopathy or other. All patients underwent electrocardiogram, 2D transthoracic echocardiogram (TTE) and cardiac magnetic resonance (CMR) before surgery for LV assessment and tissue characterization. Five patterns of LV structure were considered: normal ventricular structure (normal LV mass/volume ratio [M/V], normal LVMi and normal indexed LV end-diastolic volume (LVEDVi); concentric remodeling: increased M/V, normal LVMi; concentric hypertrophy: increased M/V and LVMi; eccentric hypertrophy: increased LVMi and LVEDVi, normal M/V and ejection fraction; and adverse remodeling: dilated left ventricle, increased LVMi and normal M/V in the context of an impaired ejection fraction. Echocardiogram and CMR structural and functional indexes were compared between these groups.
Results
At baseline study, at CMR: mean LV indexed mass [LVMi]: 80.3±26.5 g/m2; mean end-diastolic LV indexed volume [LVEDVi]: 84.4±24.5 mL/m2 and median geometric remodeling ratio [M/V]: 0.95 g/mL [IQR 0. 81–1.08 g/mL]. Overall, 22% patients had normal LV structure, 30% concentric remodeling ventricular geometry, and two patients had an adverse remodeling pattern. LV hypertrophy was the most prevalent pattern and occurred in 48% of subjects (concentric 43%; eccentric 4%). In our cohort, the severity of AS (AVmean (p<0.001), LV function (LV ejection fraction [p<0.001] and Global longitudinal strain [p<0.001]), LV loading conditions (indexed left atrial volume [p<0.001] and E/e' ratio [p<0.001]) and NT-proBNP (p<0.001) were related to the pattern of LV structure (Table 1).
Conclusions
In our cohort, AS patients presented several distinct patterns of LV remodeling. Disease severity, functional repercussion and loading conditions are distinct between them.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
| | | | - S Maltes
- Hospital Santa Cruz , Lisbon , Portugal
| | | | - L Oliveira
- Hospital Divino Espirito Santo , Ponta Delgada , Portugal
| | - E Horta
- Hospital Santa Cruz , Lisbon , Portugal
| | | | - P Freitas
- Hospital Santa Cruz , Lisbon , Portugal
| | | | | | | | - N Cardim
- Nova Medical School , Lisbon , Portugal
| | - V Gil
- Hospital da Luz, SA , Lisbon , Portugal
| | - M Mendes
- Hospital Santa Cruz , Lisbon , Portugal
| | - J P Neves
- Hospital Santa Cruz , Lisbon , Portugal
| |
Collapse
|
18
|
R Santos R, Abecasis J, Maltes S, Mendes GS, Oliveira L, Horta E, Guerreiro S, Freitas P, Ferreira A, Ribeiras R, Andrade MJ, Cardim N, Gil V, Mendes M, Neves JP. Left ventricular reverse remodeling in post operative aortic stenosis patients: prevalence and predictor(s). Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.1543] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
In patients with severe aortic stenosis (AS), left ventricular (LV) remodeling is believed to be a compensatory adaptive process which should reverse after aortic valve intervention. However, this is not always the rule and remodeling persistence may negatively impact post-procedural outcomes and survival.
Aim
To assess the prevalence and predictors of morphological LV reverse remodeling in severe symptomatic AS patients after surgical aortic valve replacement (AVR).
Methods
We prospectively studied 75 patients (72y [68–77y], 45% male) with severe symptomatic AS - mean gradient (AVM): 61±17mmHg; mean indexed aortic valve area (AVAi) 0.41±0.10 cm2/m2 with no previous history of ischemic cardiomyopathy, all with high gradient, 4 with low-flow, 81% with hypertension, 27% with type 2 diabetes mellitus and 35% patients with stage 3 chronic kidney disease: median MDR creat clearance: 70.4mL/min [40–102]. All patients performed pre-operative cardiac magnetic resonance (CMR) at a mean period of 3.4 months (0–17 months) before AVR and at the 3–6th months after AVR, for LV reverse remodeling assessment. It was defined as at least the occurrence of one of the following: >15% reduction in LVEDVi; >15% reduction in LVMi by CMR; >10% reduction in geometric remodeling ratio. Clinical, AV severity data, preoperative functional LV and tissue characterization data were analyzed at multivariate regression to predict the occurrence of LV reverse remodeling.
Results
Overall, at pre-operative CMR: mean LV indexed mass (LVMi): 82±28.9 g/m2; mean end-diastolic LV indexed volume (LVEDVi): 87.4±26.6 mL/m2; mean geometric remodeling (LV mass/end-diastolic volume): 0.92±0.2 g/mL. After AVR, at echocardiographic evaluation, no patient had prosthetic obstruction or prosthetic patient mismatch: median LV-Ao gradient 12mmHg [9.1–14 mmHg]; 5 of them had mild paravalvular regurgitation. LV reverse remodeling occurred in 65 patients (88%) (Figure 1A) and these were younger, had significantly smaller preoperative AVAi and higher valvular gradients (Figure 1B). At multivariate analysis, only preoperative AVAi remained an independent predictor (odds ratio 0.85, 95% CI 0.735–0.984, p=0.029).
Conclusions
In this prospective cohort of patients LV reverse remodeling after surgical AVR was highly frequent, occurring in almost nine out of every ten patients.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
| | | | - S Maltes
- Hospital Santa Cruz , Lisbon , Portugal
| | | | - L Oliveira
- Hospital Divino Espirito Santo , Ponta Delgada , Portugal
| | - E Horta
- Hospital Santa Cruz , Lisbon , Portugal
| | | | - P Freitas
- Hospital Santa Cruz , Lisbon , Portugal
| | | | | | | | - N Cardim
- Nova Medical School , Lisbon , Portugal
| | - V Gil
- Hospital da Luz, SA , Lisbon , Portugal
| | - M Mendes
- Hospital Santa Cruz , Lisbon , Portugal
| | - J P Neves
- Hospital Santa Cruz , Lisbon , Portugal
| |
Collapse
|
19
|
Lopes Da Cunha GJ, Lopes P, Freitas P, Rocha B, Gomes D, Paiva M, Amador R, Abecasis J, Guerreiro S, Matos D, Rodrigues G, Carvalho MS, Mendes M, Adragao P, Ferreira A. Late gadolinium enhancement is a strong predictor of life threatening arrhythmias in patients with dilated cardiomyopathy undergoing ICD implantation for primary prevention of sudden cardiac death. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.677] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
The usefulness of implantable cardioverter defibrillators (ICD) for primary prevention of arrhythmic sudden cardiac death (SCD) in patients with non-ischemic dilated cardiomyopathy (DCM) has been questioned. Efforts to improve risk stratification have included scores such as the “MADIT-ICD benefit score”, and the use of late gadolinium enhancement (LGE) in cardiac magnetic resonance (CMR).
The purpose of this study was to evaluate the potential usefulness of these two tools to assess the risk of life-threatening arrhythmias in patients with non-ischemic DCM undergoing ICD implantation for primary prevention of SCD.
Methods
We conducted a single-center retrospective study of consecutive patients who underwent contrast-enhanced CMR before ICD implantation for primary prevention of SCD. Patients with ischemic cardiomyopathy were used as reference. Patients with non-dilated cardiomyopathies were excluded.
The arrhythmic component of the MADIT-ICD benefit score (VT/VF score) was calculated for each patient, and considered high if ≥7, as recommended.
The primary endpoint was the occurrence of SCD or life-threatening arrhythmias (VF or VT >200 bpm). Follow-up was performed by device interrogation in all patients except those who suffered SCD.
Results
A total of 151 patients (93 ischemic, mean age 62±13 years, 75% male) with mean left ventricular ejection fraction (LVEF) of 27±8% were included. Overall, 72% (n=67) ischemic and 45% (n=26) non-ischemic patients had scores ≥7 and were considered high-risk. LGE was present in all patients with ischemic cardiomyopathy, and in 76% (n=44) of patients with non-ischemic DCM.
During a median follow-up of 21 (8–38) months, 21 patients (13.9%, 11 ischemic and 10 non-ischemic) met the primary endpoint.
Overall, the event-free survival of non-ischemic patients was similar to that of ischemic patients (log rank p=0.269). In patients with non-ischemic DCM, there were 7 arrhythmic events (26.9%) in those with MADIT-ICD VT/VF scores ≥7, and 3 events (9.4%) in those with scores <7 (log rank p=0.104).
In the same population, there were 10 arrhythmic events (23%) in patients with LGE, but no events in patients without LGE (log rank p=0.036).
LVEF was similar in patients with and without arrhythmic events (26±8% vs. 27±7%, p=0.717), and in those with and without LGE (26±7% vs. 28±9%, p=0.342).
Conclusion
The presence of LGE is a strong predictor of life threatening arrhythmias in patients in non-ischemic DCM undergoing ICD implantation for primary prevention, seemingly outperforming the clinical MADIT-ICD benefit score.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
| | - P Lopes
- Hospital Santa Cruz , Lisbon , Portugal
| | - P Freitas
- Hospital Santa Cruz , Lisbon , Portugal
| | - B Rocha
- Hospital Santa Cruz , Lisbon , Portugal
| | - D Gomes
- Hospital Santa Cruz , Lisbon , Portugal
| | - M Paiva
- Hospital Santa Cruz , Lisbon , Portugal
| | - R Amador
- Hospital Santa Cruz , Lisbon , Portugal
| | | | | | - D Matos
- Hospital Santa Cruz , Lisbon , Portugal
| | | | | | - M Mendes
- Hospital Santa Cruz , Lisbon , Portugal
| | - P Adragao
- Hospital Santa Cruz , Lisbon , Portugal
| | | |
Collapse
|
20
|
Maltes S, Abecasis J, Santos RR, Oliveira L, Mendes GS, Guerreiro S, Lima T, Freitas P, Ferreira A, Cardim N, Gil VM, Mendes M. Late gadolinium enhancement patterns in severe symptomatic high-gradient aortic stenosis. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.233] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Left ventricular (LV) remodeling in patients with severe aortic valve stenosis (AS) is a complex process that goes beyond hypertrophic response and may involve reparative/replacement fibrosis. Currently, cardiac magnetic resonance (CMR) is the gold-standard imaging technique for detecting focal myocardial fibrosis through late gadolinium enhancement (LGE). However, myocardial fibrosis prevalence and distribution is quite variable among series. Our goal was to assess LGE prevalence and distribution pattern in severe symptomatic high-gradient AS.
Methodology
Single-center prospective cohort of 132 patients with severe symptomatic high-gradient AS (mean age 73±11 years; 48% male, mean valvular transaortic gradient 60±20 mmHg; mean aortic valve area 0.7±0.2 cm2/m2; mean LV ejection fraction by 2D echocardiogram 58±9%), all with normal flow (except one) undergoing surgical aortic valve replacement. Those with previous history of acute myocardial infarction, ischemic cardiomyopathy or other cardiomyopathy were excluded. All patients performed 1.5T CMR assessment with LV myocardium tissue characterization prior to surgery. Segmental LGE presence was assessed by two independent operators and classified according to the AHA 16 segment model, using 5-standard deviations from remote myocardium as the signal intensity cut-off for LGE identification and quantification.
Results
Overall, 96 patients (74%) had non-ischemic LGE (median LGE mass 3.2 g [IQR 0.2–8.3] g; median percentage of LGE myocardial mass 2.5% [IQR 0.1–6.1]%); 22 patients [17%] with exclusively junctional LGE); in one patient an incidental ischemic scar (subendocardial distribution) was identified. No cases of subepicardial distribution were found. Intramyocardial LGE was most frequently observed in basal and mid-anterior and inferior interventricular septum – see Figure 1. In these segments, LGE was most often junctional at right-ventricular insertion points (54%), followed by mid-wall LGE (32%) or both sites involvement (14%).
Conclusion
LGE is frequent in symptomatic high-gradient AS patients with preserved left ventricular ejection fraction, most often presenting as junctional enhancement in basal/mid-anterior and inferior interventricular septum. Future studies may address whether distinct LGE patterns may impact patient prognosis.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- S Maltes
- Hospital Santa Cruz , Lisbon , Portugal
| | | | | | | | | | | | - T Lima
- Hospital Santa Cruz , Lisbon , Portugal
| | - P Freitas
- Hospital Santa Cruz , Lisbon , Portugal
| | | | - N Cardim
- Hospital da Luz, SA , Lisbon , Portugal
| | - V M Gil
- Hospital da Luz, SA , Lisbon , Portugal
| | - M Mendes
- Hospital Santa Cruz , Lisbon , Portugal
| |
Collapse
|
21
|
Lopes Da Cunha GJ, Rocha B, Sousa J, Maltes S, Brizido C, Strong C, Guerreiro S, Abecasis J, Andrade MJ, Aguiar C, Saraiva C, Freitas P, Mendes M, Ferreira A. Looking beyond left ventricular ejection fraction – a new multiparametric CMR score to refine the prognostic assessment of HF patients. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.850] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Cardiac magnetic resonance (CMR) is recommended in Heart Failure (HF) to assess myocardial structure and function. Recently, the quantification of pulmonary congestion and skeletal muscle mass using CMR have been shown to predict adverse events in HF, but a tool integrating this information is currently unavailable. The purpose of this study was to develop and test a new multiparametric CMR-derived score.
Methods
We conducted a single-center retrospective study of consecutive HF patients with left ventricular ejection fraction (LVEF) <50% who underwent CMR. Several CMR parameters with known prognostic value were assessed, including: LVEF, Lung Water Density (LWD), Pectoralis Major Muscle (PMM) area, and presence of Late Gadolinium Enhancement. PMM area was outlined at the level of the carina – Figure 1A, B – and LWD was defined as the lung-to-liver signal ratio multiplied by 0.7, as previously described. Both parameters were measured in standard HASTE images - Figure 1C. The primary endpoint was a composite of all-cause death or HF hospitalization. Using the Cox regression Hazard Ratios of designated variables, a risk score was developed.
Results
Overall, 436 patients were included. During a median follow-up of 27 (17–37) months, 43 (9.9%) patients died and 57 (13.2%) had at least one hospitalization for HF. LVEF, LWD and PMM were independent predictors of the primary endpoint and were included in the CMR-HF score – Figure 2. The annual rate of events increased from 4.7 to 7.5 and 20.0% from lowest to highest tertile of the score. Roughly half of the events (54%) occurred in patients in the highest tertile of the CMR-HF score. In multivariate analysis, the new score independently predicted the primary endpoint (HR per 5 points: 1.54; 95% CI: 1.21–1.97; p<0.001) even after adjustment for age, body mass index, NYHA class, NT-proBNP, estimated glomerular filtration rate, presence of implantable cardioverter-defibrillator, and ischemic etiology.
Conclusions
This novel multidimensional CMR-HF score, combining easily obtainable data on left ventricular pump failure, lung congestion and muscular wasting, is a promising tool identifying HF patients with an LVEF <50% at higher risk of death or HF hospitalization.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
| | - B Rocha
- Hospital Santa Cruz , Lisbon , Portugal
| | - J Sousa
- Hospital Santa Cruz , Lisbon , Portugal
| | - S Maltes
- Hospital Santa Cruz , Lisbon , Portugal
| | - C Brizido
- Hospital Santa Cruz , Lisbon , Portugal
| | - C Strong
- Hospital Santa Cruz , Lisbon , Portugal
| | | | | | | | - C Aguiar
- Hospital Santa Cruz , Lisbon , Portugal
| | - C Saraiva
- Hospital Santa Cruz , Lisbon , Portugal
| | - P Freitas
- Hospital Santa Cruz , Lisbon , Portugal
| | - M Mendes
- Hospital Santa Cruz , Lisbon , Portugal
| | | |
Collapse
|
22
|
Bento H, Ferreira A, Iglesias G, Curcio F, Lima HA, Araújo T, Kuczmarski A, Paz R. Testicle histology of the Epicrates cenchria: a morphological and reproductive biology analysis. ARQ BRAS MED VET ZOO 2022. [DOI: 10.1590/1678-4162-12657] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
ABSTRACT The lack of information about anatomy, physiology and reproductive biology in many snake species makes the understanding of these free-living animals’ reproduction and reproductive biotechnics application in captivity difficult. The present study aims to evaluate the Epicrates cenchria’s testicle morphology and correlate these findings with environmental aspects and reproductive biology. The testicles of five specimens of E. cenchria were histologically evaluated, and it was possible to observe seasonality in sperm production, with the presence of mature spermatozoa in the wettest and warmest periods of the year, as well as the highest testicular volume in these periods. Correlating these findings with that reported in the literature on copulation period presupposes a prenuptial (or associated) pattern in E. cenchria.
Collapse
Affiliation(s)
- H.J. Bento
- Universidade Federal do Mato Grosso, Brazil; Universidade Federal do Mato Grosso, Brazil
| | | | - G.A. Iglesias
- Universidade Federal do Mato Grosso, Brazil; Universidade Federal do Mato Grosso, Brazil
| | | | | | | | - A.H. Kuczmarski
- Universidade Federal do Mato Grosso, Brazil; Universidade Federal do Mato Grosso, Brazil
| | - R.C.R. Paz
- Universidade Federal do Mato Grosso, Brazil; Universidade Federal do Mato Grosso, Brazil
| |
Collapse
|
23
|
Almeida F, Rocha F, Teixeira J, Ferreira A. The influence of electrolytes in aqueous solutions on gas-liquid mass transfer in an oscillatory flow reactor. Chem Eng Sci 2022. [DOI: 10.1016/j.ces.2022.118048] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
24
|
Lavratti C, Iraci L, Ferreira A, Dorneles G, Pochmann D, da Rosa Boeira M, Peres A, Elsner V. Time course of epigenetic modulation in response to concurrent exercise training in patients with schizophrenia. Comparative Exercise Physiology 2022. [DOI: 10.3920/cep210013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
This study aimed to investigate the short and long-term effects of concurrent exercise training on anthropometric variables, HDCA2 activity and cortisol levels of individuals with schizophrenia (SZ). Therefore, 10 patients were submitted to the program (endurance and strength exercises in the same session, 60 min of duration, three times a week) and blood samples were collected before, 30 days and 180 days after the intervention started. Exercise training reduced the body mass index and body mass after 180 days of the intervention. A significant decrease on HDAC2 activity was found 180 days after intervention compared to before the intervention. The cortisol levels remained unchanged in any evaluated time-points. The concurrent exercise training was able to modulate HDAC2 activity in mononuclear cells and improve anthropometric variables in a time-dependent manner in patients with SZ.
Collapse
Affiliation(s)
- C. Lavratti
- Programa de Pós Graduação em Ciências da Reabilitação, Universidade Federal de Ciências da Saúde de Porto Alegre, Rua Coronel Joaquim Pedro Salgado 80, Rio Branco, CEP 90420-060 Porto Alegre, RS, Brazil
| | - L. Iraci
- Curso de Fisioterapia do Centro Universitário Metodista-IPA, Porto Alegre, RS, Brazil
| | - A. Ferreira
- Curso de Fisioterapia do Centro Universitário Metodista-IPA, Porto Alegre, RS, Brazil
| | - G. Dorneles
- Cellular and Molecular Immunology Lab., Department of Health Basic Sciences. Federal University of Health Sciences of Porto Alegre, Porto Alegre, RS, Brazil
| | - D. Pochmann
- Programa de Pós Graduação em Biociências e Reabilitação doCentro Universitário Metodista-IPA, Porto Alegre, RS, Brazil
| | - M.C. da Rosa Boeira
- Programa de Pós Graduação em Ciências da Reabilitação, Universidade Federal de Ciências da Saúde de Porto Alegre, Rua Coronel Joaquim Pedro Salgado 80, Rio Branco, CEP 90420-060 Porto Alegre, RS, Brazil
| | - A. Peres
- Cellular and Molecular Immunology Lab., Department of Health Basic Sciences. Federal University of Health Sciences of Porto Alegre, Porto Alegre, RS, Brazil
| | - V.R. Elsner
- Cellular and Molecular Immunology Lab., Department of Health Basic Sciences. Federal University of Health Sciences of Porto Alegre, Porto Alegre, RS, Brazil
- Programa de Pós Graduação em Biociências e Reabilitação doCentro Universitário Metodista-IPA, Porto Alegre, RS, Brazil
- Programa de Pós Graduação em Ciências Biológicas: Fisiologia, Universidade Federal do Rio Grande do Sul, Brazil
| |
Collapse
|
25
|
Lopes P, Albuquerque F, Freitas P, Gonçalves P, Presume J, Guerreiro S, Abecasis J, Santos A, Saraiva C, Mendes M, Marques H, Ferreira A. 494 Influence Of Age On The Diagnostic Value Of Coronary Artery Calcium Score For Ruling Out Coronary Stenosis In Symptomatic Patients. J Cardiovasc Comput Tomogr 2022. [DOI: 10.1016/j.jcct.2022.06.105] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
26
|
Paiva M, Santos R, Freitas P, Gomes D, Presume J, Lopes P, Matos D, Guerreiro S, Santos A, Saraiva C, Mendes M, Ferreira A. 461 Use Of Coronary Calcium Score To Refine The Cardiovascular Risk Classification Of The New Score-2 And Score-2 Op Algorithms In Patients Undergoing Coronary Ct Angiography. J Cardiovasc Comput Tomogr 2022. [DOI: 10.1016/j.jcct.2022.06.066] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
27
|
Paiva M, Gomes D, Freitas P, Presume J, Santos R, Lopes P, Matos D, Guerreiro S, Abecasis J, Santos A, Saraiva C, Mendes M, Ferreira A. 468 Potential Impact Of Replacing Score With Score-2 On Risk Classification And Statin Eligibility - A Coronary Calcium Score Correlation Study. J Cardiovasc Comput Tomogr 2022. [DOI: 10.1016/j.jcct.2022.06.079] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
28
|
Vasques A, Baleiras M, Ferreira A, Duarte T, Branco V, Pereira J, Lobo-Martins S, Pinto M, Martins A. P-59 Real-world data of trastuzumab in metastatic cancer. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.04.149] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
29
|
Parreira A, Carmo P, Mesquita D, Marques L, Chambel D, Pinho J, Ferreira A, Amador P, Chmelevsky M, Machado P, Ferreira J, Nunes S, Goncalves P, Marques H, Adragao P. Electrocardiographic imaging a valid tool or an inaccurate toy? Europace 2022. [DOI: 10.1093/europace/euac053.025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Private hospital(s). Main funding source(s): Learning Health
Background and aim
Electrocardiographic imaging (ECGI) is capable of performing an activation map with a single beat. However, previous studies using the epicardial-only system, have suggested a bad accuracy for the assessment of the epicardial breakthrough. Recent systems using endo-epicardial analysis have shown promising results. The aim of this study was to assess the accuracy and reproducibility of two endo-epicardial ECGI systems using different cardiac sources one based on the extracellular-potential, and the other on the equivalent double layer model, respectively the AMYCARD (EP Solutions SA, Switzerland) and VIVO (Catheter Precision, NJ USA) systems.
Methods
We studied 11 consecutive patients referred for ablation of frequent idiopathic premature ventricular contractions at our center that had an ECGI performed using both systems on the same day. The AMYCARD system uses a dense array of body-surface electrocardiograms with up to 224 leads and VIVO uses just the 12-leads ECG. Both systems use a patient-specific heart torso geometry obtained with a CT-scan or cardiac magnetic resonance. The localisation of the PVCs based on ECGI was done using a segmental model with 22 segments on the left ventricle, to include the classical 17 segment model plus the aortic cusps and the papillary muscles, and 12 segments on the right ventricle including 4 on the right ventricular outflow tract (RVOT): (anterior, lateral, right septum and left septum). A perfect match was defined as a predicted location within the same anatomic segment, whereas a near match as a predicted location within the same segment or a contiguous one.
Results
The median (Q1-Q3) number of leads used for the AMYCARD was 131 (118-144). Seven patients underwent ablation and in 4 ablation is pending. The predicted locations and the ablation site are depicted on the Table. We found a perfect match between both systems in 73% (Figure) and near match in 91% of cases. In patients that underwent ablation the systems localised the site of origin of the PVCs within the same segment or the contiguous segment in all patients with VIVO and in six out of seven with AMYCARD.
Conclusions
ECGI is an accurate diagnostic tool with reproducible results regardless the cardiac source used for analysis.
Collapse
Affiliation(s)
| | - P Carmo
- Hospital Luz, Lisbon, Portugal
| | - D Mesquita
- Hospital Center of Setubal, Setubal, Portugal
| | - L Marques
- Hospital Center of Setubal, Setubal, Portugal
| | - D Chambel
- Hospital Center of Setubal, Setubal, Portugal
| | - J Pinho
- Hospital Luz, Lisbon, Portugal
| | | | - P Amador
- Hospital Center of Setubal, Setubal, Portugal
| | - M Chmelevsky
- Almazov National Medical Research Center, St Petersburg, Russian Federation
| | | | - J Ferreira
- Hospital Center of Setubal, Setubal, Portugal
| | - S Nunes
- Hospital Luz, Lisbon, Portugal
| | | | | | | |
Collapse
|
30
|
Santos M, Silva M, Guerreiro S, Gomes D, Rocha B, Cunha G, Freitas P, Abecasis J, Carmo P, Cavaco D, Morgado F, Adragao P, Mendes M, Ferreira A. A cardiac magnetic resonance myocardial strain patterns analysis in left bundle branch block. Europace 2022. [DOI: 10.1093/europace/euac053.033] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
Introduction
Recently, a classification with four types of septal longitudinal strain patterns was described using a speckle tracking based strain analysis in echocardiography suggesting pathophysiological continuum of LBBB-induced LV remodeling. Little data exist on feature tracking cardiac magnetic resonance (FT-CMR) in LBBB patients, and whether such patterns could be reproduced in CMR is not established yet.
Purpose
In this study, we aimed to: 1) Assess and reproduce the new strain patterns classification by CMR and 2) Evaluate its association with LV remodeling and myocardial scar in a LBBB cohort.
Methods
Single center registry which included LBBB patients with septal flash (SF) referred to CMR to assess the structural cause of LV dysfunction. LBBB was defined according to Strauss criteria as strict LBBB, non-strict LBBB or nonspecific LV conduction delay.
A semi-automated FT-CMR was used to quantify myocardial strain and detect the four septal longitudinal and radial strain patterns, according to the recent classification (LBBB-1 through LBBB-4) – Figure. Extent of SF was visually scored as mild, moderate, or prominent.
Results
A total of 115 patients were included (mean age 66±11 years; 57% men; 38% with ischemic heart disease). Median duration of QRS was 150± 26ms and majority of the patients (n=90, 78%) were classified as strict LBBB.
In longitudinal strain analyses LBBB-1 was observed in 23 (20%), LBBB-2 in 37 (32.1%), LBBB-3 in 25 (21.7%), and LBBB-4 in 30 (26%) patients. Patients at higher LBBB stages (longitudinal or radial pattern) had more prominent septal flash, greater LV volumes, lower LV ejection fraction and lower absolute global longitudinal, circumferential and radial strain values compared with patients in less advanced stages (p < 0.05 for all) - table.
There was no difference between patterns in clinical characteristics, ischemic etiology, QRS duration and time delay between septal and lateral LV wall.
Late gadolinium enhancement (LGE) was found in 63 patients (54.8%), with a septal location in 34 (29.6%) patients, lateral in 4 (3.5%) patients, septal and lateral in 11 (9.6%) patients. Furthermore, no difference was found for LGE presence, distribution or location between the four strain patterns.
Conclusions
Among patients with LBBB, our study found a good association between longitudinal and radial strain patterns with the degree of LV remodeling and LV dysfunction by FT-CMR analysis. Additionally, myocardial fibrosis didn’t seem to interfere with the staged LBBB classification.
Collapse
Affiliation(s)
- M Santos
- Hospital Funchal, Funchal, Portugal
| | - M Silva
- Centro Hospitalar Barreiro Montijo, Lisboa, Portugal
| | - S Guerreiro
- Centro Hospitalar de Lisboa Ocidental, Hospital de Santa Cruz, Lisbon, Portugal
| | - D Gomes
- Centro Hospitalar de Lisboa Ocidental, Hospital de Santa Cruz, Lisbon, Portugal
| | - B Rocha
- Centro Hospitalar de Lisboa Ocidental, Hospital de Santa Cruz, Lisbon, Portugal
| | - G Cunha
- Centro Hospitalar de Lisboa Ocidental, Hospital de Santa Cruz, Lisbon, Portugal
| | - P Freitas
- Centro Hospitalar de Lisboa Ocidental, Hospital de Santa Cruz, Lisbon, Portugal
| | - J Abecasis
- Centro Hospitalar de Lisboa Ocidental, Hospital de Santa Cruz, Lisbon, Portugal
| | - P Carmo
- Centro Hospitalar de Lisboa Ocidental, Hospital de Santa Cruz, Lisbon, Portugal
| | - D Cavaco
- Centro Hospitalar de Lisboa Ocidental, Hospital de Santa Cruz, Lisbon, Portugal
| | - F Morgado
- Centro Hospitalar de Lisboa Ocidental, Hospital de Santa Cruz, Lisbon, Portugal
| | - P Adragao
- Centro Hospitalar de Lisboa Ocidental, Hospital de Santa Cruz, Lisbon, Portugal
| | - M Mendes
- Centro Hospitalar de Lisboa Ocidental, Hospital de Santa Cruz, Lisbon, Portugal
| | - A Ferreira
- Centro Hospitalar de Lisboa Ocidental, Hospital de Santa Cruz, Lisbon, Portugal
| |
Collapse
|
31
|
Lopes Da Cunha GJ, Lopes P, Freitas PN, Matos D, Rodrigues G, Carmo J, Carvalho S, Santos PG, Costa FM, Carmo P, Cavaco D, Morgado F, Mendes M, Ferreira A, Adragao P. Late gadolinium enhancement is a strong predictor of life threatening arrhythmias in patients with non-ischemic dilated cardiomyopathy undergoing ICD implantation for primary prevention of sudden card. Europace 2022. [DOI: 10.1093/europace/euac053.335] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
Background
The usefulness of implantable cardioverter defibrillators (ICD) for primary prevention of arrhythmic sudden cardiac death (SCD) in patients with non-ischemic dilated cardiomyopathy (DCM) has been questioned. Efforts to improve risk stratification have included scores such as the ‘MADIT-ICD benefit score’, and the use of late gadolinium enhancement (LGE) in cardiac magnetic resonance (CMR).
The purpose of this study was to evaluate the potential usefulness of these two tools to assess the risk of life-threatening arrhythmias in patients with non-ischemic DCM undergoing ICD implantation for primary prevention of SCD.
Methods
We conducted a single-center retrospective study of consecutive patients who underwent contrast-enhanced CMR before ICD implantation for primary prevention of SCD. Patients with ischemic cardiomyopathy were used as reference. Patients with non-dilated cardiomyopathies were excluded.
The arrhythmic component of the MADIT-ICD benefit score (VT/VF score) was calculated for each patient, and considered high if ≥ 7, as recommended.
The primary endpoint was the occurrence of SCD or life-threatening arrhythmias (VF or VT >200 bpm). Follow-up was performed by device interrogation in all patients except those who suffered SCD.
Results
A total of 151 patients (93 ischemic, mean age 62±13 years, 75% male) with mean left ventricular ejection fraction (LVEF) of 27±8% were included. Overall, 72% (n=67) ischemic and 45% (n=26) non-ischemic patients had scores ≥ 7 and were considered high-risk. LGE was present in all patients with ischemic cardiomyopathy, and in 76% (n=44) of patients with non-ischemic DCM.
During a median follow-up of 21 (8-38) months, 21 patients (13.9%, 11 ischemic and 10 non-ischemic) met the primary endpoint.
Overall, the event-free survival of non-ischemic patients was similar to that of ischemic patients (log rank p=0.269) – Fig 1A. In patients with non-ischemic DCM, there were 7 arrhythmic events (26.9%) in those with MADIT-ICD VT/VF scores ≥7, and 3 events (9.4%) in those with scores <7 (log rank p= 0.104) – Fig 1B.
In the same population, there were 10 arrhythmic events (23%) in patients with LGE, but no events in patients without LGE (log rank p=0.036) – Fig 1C.
LVEF was similar in patients with and without arrhythmic events (26±8% vs. 27±7%, p=0.717), and in those with and without LGE (26±7% vs. 28±9%, p=0.342).
Conclusion
The presence of LGE is a strong predictor of life threatening arrhythmias in patients in non-ischemic DCM undergoing ICD implantation for primary prevention, seemingly outperforming the clinical MADIT-ICD benefit score.
Collapse
Affiliation(s)
| | - P Lopes
- Hospital Santa Cruz, Lisbon, Portugal
| | | | - D Matos
- Hospital Santa Cruz, Lisbon, Portugal
| | | | - J Carmo
- Hospital Santa Cruz, Lisbon, Portugal
| | | | - PG Santos
- Hospital Santa Cruz, Lisbon, Portugal
| | - FM Costa
- Hospital Santa Cruz, Lisbon, Portugal
| | - P Carmo
- Hospital Santa Cruz, Lisbon, Portugal
| | - D Cavaco
- Hospital Santa Cruz, Lisbon, Portugal
| | - F Morgado
- Hospital Santa Cruz, Lisbon, Portugal
| | - M Mendes
- Hospital Santa Cruz, Lisbon, Portugal
| | | | - P Adragao
- Hospital Santa Cruz, Lisbon, Portugal
| |
Collapse
|
32
|
Lopes P, Cunha G, Freitas P, Rocha B, Matos D, Rodrigues G, Carmo J, Carvalho MS, Galvao Santos P, Costa FM, Carmo P, Cavaco D, Morgado F, Ferreira A, Adragao P. The peri-infarct gray zone of myocardial fibrosis is a better predictor of ventricular arrhythmias than dense core fibrosis in patients with previous myocardial infarction. Europace 2022. [DOI: 10.1093/europace/euac053.340] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
Background
Current sudden cardiac death (SCD) risk stratification relies heavily on left ventricular ejection fraction (LVEF), but markers to refine risk assessment are needed. Dense core fibrosis (DCF) and peri-infarct "gray zone" of myocardial fibrosis (GZF) on late gadolinium enhancement (LGE) cardiac magnetic resonance (CMR) have been proposed as potential arrhythmogenic substrates. The aim of our study was to determine whether DCF and GZF could predict the occurrence of ventricular arrhythmias in patients with previous myocardial infarction.
Methods
We performed a single centre retrospective study enrolling consecutive patients with previous myocardial infarction undergoing CMR before implantable cardioverter-defibrillator (ICD) implantation. Areas of LGE were subdivided into "core" DCF and "peri-infarct" GZF zones based on signal intensity (>5 SD, and 2-5 SD above the mean of reference myocardium, respectively).
The primary endpoint was a composite of sudden arrhythmic death, appropriate ICD shock, ventricular fibrillation (VF), or sustained ventricular tachycardia (VT) as detected by the device.
Results
A total of 88 patients (median age 61 years [IQR 54-73], 84% male, median LVEF 30% [IQR 23-36%], 14% secondary prevention) were included. During a median follow-up of 23 months [IQR 9-38], 13 patients reached the primary endpoint (10 appropriate ICD shock, 2 sustained VT or VF, and 1 sudden arrhythmic death). Patients who attained the primary endpoint had similar DCF (30.4g ± 14.7 vs. 28.0g ± 15.3; P = 0.601) but a greater amount of GZF (18.1g ± 9.6 vs. 11.9g ± 6.7; P = 0.005). On univariate analysis, GZF was associated with the composite endpoint (HR: 1.09 per gram; 95%CI: 1.02-1.15; P = 0.006), whereas DCF was not (HR: 1.01 per gram; 95%CI: 0.98-1.05; P = 0.571). After adjustment for LVEF, GZF remained independently associated with the primary endpoint (adjusted HR: 1.06 per gram; 95% CI: 1.01-1.12; P = 0.035). Decision tree analysis identified 11.9g of GZF as the best cut-off to predict life-threatening arrhythmic events. The primary endpoint occurred in 11 out of the 35 patients (31.4%) with GZF ≥11.9g, but in only 2 of the 53 patients (3.8%) with GZF <11.9g – Figure.
Conclusions
The extent of peri-infarct GZF seems to be a better predictor of ventricular arrhythmias than DCF. This parameter may be useful to identify a subgroup of patients with previous myocardial infarction at increased risk of life-threatening arrhythmic events.
Collapse
Affiliation(s)
- P Lopes
- Hospital Santa Cruz, Carnaxide, Portugal
| | - G Cunha
- Hospital Santa Cruz, Carnaxide, Portugal
| | - P Freitas
- Hospital Santa Cruz, Carnaxide, Portugal
| | - B Rocha
- Hospital Santa Cruz, Carnaxide, Portugal
| | - D Matos
- Hospital Santa Cruz, Carnaxide, Portugal
| | | | - J Carmo
- Hospital Santa Cruz, Carnaxide, Portugal
| | | | | | - FM Costa
- Hospital Santa Cruz, Carnaxide, Portugal
| | - P Carmo
- Hospital Santa Cruz, Carnaxide, Portugal
| | - D Cavaco
- Hospital Santa Cruz, Carnaxide, Portugal
| | - F Morgado
- Hospital Santa Cruz, Carnaxide, Portugal
| | - A Ferreira
- Hospital Santa Cruz, Carnaxide, Portugal
| | - P Adragao
- Hospital Santa Cruz, Carnaxide, Portugal
| |
Collapse
|
33
|
Parreira A, Carmo P, Marinheiro R, Mesquita D, Marques L, Mancelos S, Ferreira A, Goncalves A, Nunes S, Chmelevsky M, Ferreira J, Coelho R, Goncalves P, Marques H, Adragao P. Assessment of activation duration across the right ventricular outflow tract in patients with premature ventricular contractions using noninvasive electrocardiographic mapping: a validation study. Europace 2022. [DOI: 10.1093/europace/euac053.024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Private hospital(s). Main funding source(s): Learning Health
Introduction
Previous studies have reported that wavefront propagation speed across the right ventricular outflow tract (RVOT) can distinguish premature ventricular contractions (PVCs) with a RVOT origin from PVCs with a left ventricular outflow tract (LVOT) origin.
Aim
Validate the non-invasive electrocardiographic mapping (ECGI) for assessment of RVOT activation duration (AD) during PVCs and assess its value as a predictor of the origin of the PVCs.
Methods
We studied 18 consecutive patients, 8 males, median age 55 (35-63) years that underwent ablation of frequent (> 10.000 per 24 h) idiopathic PVCs with inferior axis, that had and an ECGI performed before ablation and the RVOT mapped in PVC. The ECGI was performed with the Amycard system, and invasive mapping was performed with the Carto or Ensite system. Isochronal activation maps of the RVOT in PVC were obtained with the activation direction method (ADM) of the ECGI, and with the Carto and Ensite systems. Total RVOT AD was measured as the time interval between the earliest and the latest activated region. Agreement between the two methods was performed using a Bland-Altman plot and linear regression . The cutoff value of AD to predict PVC origin was calculated with ROC curve.
Results
PVCs originated from the RVOT in 11 (61%) patients. The median (Q1-Q3) RVOT AD measured with ECGI was 54 (39-68) ms and with invasive map 57 (36-70) ms. The agreement between both methods was good with an R2 of 0.747, p<0.0001. Figure displays the Bland-Altman plot (panel A), the linear regression plot (panel B). and two examples of the ECGI isochronal map (panel C). The AD was significantly higher in PVCs from the RVOT vs LVOT, both with ECGI and Carto, respectively 62 (58-73) vs 37 (33-40) ms, p<0.0001 and 68 (60-75) vs 34 (30-40) ms, p<0.0001. The cutoff value of 43 ms for AD measured with ECGI, predicted the origin of the PVCs with a sensitivity and specificity of 100%.
Conclusions
We found good agreement between ECGI and Carto. The AD obtained with ECGI was accurate to predict the origin of the PVCs.
Collapse
Affiliation(s)
| | - P Carmo
- Hospital Luz, Lisbon, Portugal
| | | | - D Mesquita
- Hospital Center of Setubal, Setubal, Portugal
| | - L Marques
- Hospital Center of Setubal, Setubal, Portugal
| | | | | | - A Goncalves
- Hospital Center of Setubal, Setubal, Portugal
| | - S Nunes
- Hospital Luz, Lisbon, Portugal
| | - M Chmelevsky
- Almazov National Medical Research Center, St Petersburg, Russian Federation
| | - J Ferreira
- Hospital Center of Setubal, Setubal, Portugal
| | - R Coelho
- Hospital Center of Setubal, Setubal, Portugal
| | | | | | | |
Collapse
|
34
|
Meira de Carvalho M, Ferreira A, Costa A, Nazaré A. 201 Trisomy 2 mosaicism as a rare cause of a polymalformed foetus. Eur J Obstet Gynecol Reprod Biol 2022. [DOI: 10.1016/j.ejogrb.2021.11.063] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
35
|
Araújo N, Costa A, Lopes-Conceição L, Ferreira A, Carneiro F, Oliveira J, Braga I, Morais S, Pacheco-Figueiredo L, Ruano L, Cruz VT, Pereira S, Lunet N. Androgen deprivation therapy and cognitive decline in the NEON-PC prospective study, during the COVID-19 pandemic. ESMO Open 2022; 7:100448. [PMID: 35344749 PMCID: PMC8898674 DOI: 10.1016/j.esmoop.2022.100448] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2021] [Revised: 01/25/2022] [Accepted: 02/20/2022] [Indexed: 12/24/2022] Open
Affiliation(s)
- N Araújo
- EPIUnit - Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal; Laboratório Para a Investigação Integrativa e Translacional em Saúde Populacional (ITR), Porto, Portugal
| | - A Costa
- EPIUnit - Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal; Laboratório Para a Investigação Integrativa e Translacional em Saúde Populacional (ITR), Porto, Portugal
| | - L Lopes-Conceição
- EPIUnit - Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal
| | - A Ferreira
- Instituto Português de Oncologia do Porto, Rua Dr. António Bernardino de Almeida, Porto, Portugal
| | - F Carneiro
- Instituto Português de Oncologia do Porto, Rua Dr. António Bernardino de Almeida, Porto, Portugal
| | - J Oliveira
- Instituto Português de Oncologia do Porto, Rua Dr. António Bernardino de Almeida, Porto, Portugal
| | - I Braga
- Instituto Português de Oncologia do Porto, Rua Dr. António Bernardino de Almeida, Porto, Portugal
| | - S Morais
- EPIUnit - Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal; Laboratório Para a Investigação Integrativa e Translacional em Saúde Populacional (ITR), Porto, Portugal. https://twitter.com/samanthafmorais
| | - L Pacheco-Figueiredo
- Instituto de Investigação em Ciências da Vida e Saúde, Escola de Medicina da Universidade do Minho, Campus de Gualtar, Braga, Portugal
| | - L Ruano
- EPIUnit - Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal; Laboratório Para a Investigação Integrativa e Translacional em Saúde Populacional (ITR), Porto, Portugal. https://twitter.com/lmruano
| | - V T Cruz
- EPIUnit - Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal; Laboratório Para a Investigação Integrativa e Translacional em Saúde Populacional (ITR), Porto, Portugal
| | - S Pereira
- EPIUnit - Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal; Laboratório Para a Investigação Integrativa e Translacional em Saúde Populacional (ITR), Porto, Portugal; Instituto Português de Oncologia do Porto, Rua Dr. António Bernardino de Almeida, Porto, Portugal
| | - N Lunet
- EPIUnit - Instituto de Saúde Pública, Universidade do Porto, Porto, Portugal; Laboratório Para a Investigação Integrativa e Translacional em Saúde Populacional (ITR), Porto, Portugal; Departamento de Ciências da Saúde Pública e Forenses e Educação Médica, Faculdade de Medicina da Universidade do Porto, Alameda Professor Hernâni Monteiro, Porto, Portugal.
| |
Collapse
|
36
|
Meira de Carvalho M, Rodrigues M, Ferreira A, Costa A, Nazaré A. 203 Off-label use of femostop® to treat postpartum haemorrhage. Eur J Obstet Gynecol Reprod Biol 2022. [DOI: 10.1016/j.ejogrb.2021.11.250] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
37
|
Gomes D, Lopes P, Freitas P, Albuquerque F, Horta E, Reis C, Guerreiro S, Abecassis J, Trabulo M, Ferreira A, Ferreira J, Ribeiras R, Mendes M, Andrade MJ. Prognostic significance of peak atrial longitudinal strain in patients with functional mitral regurgitation. Eur Heart J Cardiovasc Imaging 2022. [DOI: 10.1093/ehjci/jeab289.072] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
Background
Chronic mitral regurgitation has been shown to promote left atrial (LA) dysfunction and remodeling. However, the significance of LA dysfunction in this setting has not been fully investigated. The aim of our study was to assess the prognostic impact of peak atrial longitudinal strain (PALS), a surrogate of LA function, in a cohort of patients with LV systolic dysfunction and functional mitral regurgitation (FMR).
Methods
Patients with at least mild FMR and reduced LVEF (< 50%) under optimized medical therapy who underwent transthoracic echocardiography between 2010 and 2018 were retrospectively identified at a single-centre. FMR grading was undertaken according to the new 2021 valvular guidelines. PALS was assessed by 2D speckle tracking in apical 4-chamber view (as per EACVI current recommendations). Cox proportional hazards regression was applied for univariable and multivariable analysis to investigate the association between clinical and echocardiographic parameters, namely PALS, and all-cause mortality.
Results
A total of 307 patients (median age 70 years, 77% male) were included. Median LVEF was 35% (IQR: 27 – 40%) and median mitral regurgitant volume was 25mL (IQR: 14 – 34mL). According to the new ESC 2021 valvular guidelines, 32 patients had severe FMR (10%). During a median follow-up of 3.5 years (IQR 1.4 – 6.6), 148 patients died. Median PALS was 14% (IQR 8 – 20%). The unadjusted mortality incidence per 100 persons-years increased with progressively lower values of PALS (figure 1). On ROC curve analysis, the best PALS cut-off value associated with mortality was < 15%. Kaplan-Meier survival curves according to FMR severity and PALS > or < 15% are depicted in figure 2. PALS remained independently associated with all-cause mortality on multivariable analysis (adjusted hazard ratio [aHR]: 0.94; 95%CI: 0.90 – 0.98; p = 0.004) even after adjustment for several (n = 14) clinical and echocardiographic confounders.
Conclusion
In a cohort of patients with reduced LVEF and functional mitral regurgitation, peak atrial longitudinal strain was associated with all-cause mortality. Abstract Figure 1 Abstract Figure 2
Collapse
Affiliation(s)
- D Gomes
- Hospital Santa Cruz, Lisbon, Portugal
| | - P Lopes
- Hospital Santa Cruz, Lisbon, Portugal
| | - P Freitas
- Hospital Santa Cruz, Lisbon, Portugal
| | | | - E Horta
- Hospital Santa Cruz, Lisbon, Portugal
| | - C Reis
- Hospital Santa Cruz, Lisbon, Portugal
| | | | | | - M Trabulo
- Hospital Santa Cruz, Lisbon, Portugal
| | | | | | | | - M Mendes
- Hospital Santa Cruz, Lisbon, Portugal
| | | |
Collapse
|
38
|
Ferreira A, Chambel S, Avelino A, Antunes Lopes T, Duarte Cruz C. Beyond the bladder: Evidence of histological rearrangement and urethral denervation after thoracic spinal cord injury. Eur Urol 2022. [DOI: 10.1016/s0302-2838(22)01050-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
39
|
Garagarza C, Valente A, Caetano C, Ramos I, Sebastião J, Pinto M, Oliveira T, Ferreira A, Guerreiro CS. Do dietary patterns influence survival in hemodialysis patients? Clin Nutr ESPEN 2021. [DOI: 10.1016/j.clnesp.2021.09.344] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
40
|
Fecchio A, Lugarini C, Ferreira A, Weckstein JD, Kuabara KMD, De La Torre GM, Ogrzewalska M, Martins TF, de Angeli Dutra D. Migration and season explain tick prevalence in Brazilian birds. Med Vet Entomol 2021; 35:547-555. [PMID: 34018221 DOI: 10.1111/mve.12532] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/24/2021] [Revised: 05/06/2021] [Accepted: 05/10/2021] [Indexed: 06/12/2023]
Abstract
Neotropical birds are mostly parasitized by immature ticks and act as reservoir hosts of tick-borne pathogens of medical and veterinary interest. Hence, determining the factors that enable ticks to encounter these highly mobile hosts and increase the potential for tick dispersal throughout migratory flyways are important for understanding tick-borne disease transmission. We used 9682 individual birds from 572 species surveyed across Brazil and Bayesian models to disentangle possible avian host traits and climatic drivers of infestation probabilities, accounting for avian host phylogenetic relationships and spatiotemporal factors that may influence tick prevalence. Our models revealed that the probability of an individual bird being infested with tick larvae and nymphs was lower in partial migrant hosts and during the wet season. Notably, infestation probability increased in areas with a higher proportion of partial migrant birds. Other avian ecological traits known to influence tick prevalence (foraging habitat and body mass) and environmental condition that might constrain tick abundance (annual precipitation and minimum temperature) did not explain infestation probability. Our findings suggest that migratory flyways harbouring a greater abundance of migrant bird hosts also harbour a higher prevalence of immature ticks with potential to enhance the local transmission of tick-borne pathogens and spread across regions.
Collapse
Affiliation(s)
- A Fecchio
- Programa de Pós-graduação em Ecologia e Conservação da Biodiversidade, Universidade Federal de Mato Grosso, Cuiabá, Brazil
| | - C Lugarini
- Centro Nacional de Pesquisa e Conservação de Aves Silvestres, Instituto Chico Mendes de Conservação da Biodiversidade, Florianópolis, Brazil
| | - A Ferreira
- Universidade Federal de Santa Catarina, Florianópolis, Brazil
| | - J D Weckstein
- Department of Ornithology, Academy of Natural Sciences of Drexel University, Philadelphia, PA, U.S.A
- Department of Biodiversity, Earth, and Environmental Sciences, Drexel University, Philadelphia, PA, U.S.A
| | - K M D Kuabara
- Department of Ornithology, Academy of Natural Sciences of Drexel University, Philadelphia, PA, U.S.A
- Department of Biodiversity, Earth, and Environmental Sciences, Drexel University, Philadelphia, PA, U.S.A
| | - G M De La Torre
- Programa de Pós-graduação em Ecologia e Conservação, Universidade Federal do Paraná, Curitiba, Brazil
| | - M Ogrzewalska
- Laboratório de Vírus Respiratórios e Sarampo, Instituto Oswaldo Cruz-IOC, Fundação Oswaldo Cruz-FIOCRUZ, Rio de Janeiro, Brazil
| | - T F Martins
- Departamento de Laboratórios Especializados, Superintendência de Controle de Endemias-SUCEN, Secretaria de Estado da Saúde de São Paulo, São Paulo, Brazil
- Departamento de Medicina Veterinária Preventiva e Saúde Animal, Faculdade de Medicina Veterinária e Zootecnia, Universidade de São Paulo, São Paulo, Brazil
| | | |
Collapse
|
41
|
Ferreira A, Miranda Baleiras M, Vasques A, Neves M, Ferreira F, Malheiro M, Martins A. Sexual function in testicular cancer survivors. EUR UROL SUPPL 2021. [DOI: 10.1016/s2666-1683(21)03178-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
42
|
Araujo N, Costa A, Lopes-Conceição L, Ferreira A, Carneiro F, Oliveira J, Morais S, Ruano L, Pereira S, Lunet N. Prevalence of cognitive impairment before treatments for prostate cancer. Eur J Public Health 2021. [DOI: 10.1093/eurpub/ckab165.259] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background/Objective
Up to 30% of patients with cancer may present cognitive impairment (CI) before treatment but data are scarce regarding prostate cancer (PCa). We aim to estimate the prevalence of CI in patients with PCa, before cancer treatment.
Methods
Between February 2018 and April 2021, the NEON-PC cohort included 609 patients with a recent PCa diagnosis to be treated at Instituto Português de Oncologia do Porto. Previous history of chemotherapy, radiotherapy, androgen deprivation therapy, and neurologic or psychyatric conditions impairing cognitive performance were exclusion criteria. The Montreal Cognitive Assessment (MoCA) was used to assess cognitive performance before any treatment for PCa. Participants with a MoCA at least 1.5 SD below age- and education-specific norms were considered to have probable cognitive impairment (PCI) and were proposed for a comprehensive neuropsychological (NP) assessment. Participants scoring <2.0 SD age-corrected norms in at least one cognitive test, or < 1.5 SD age-corrected norms in ≥ 2 cognitive tests were classified as having CI. Data from the population-based cohort EPIPorto (n = 351 men, evaluated in 2013-2015) were used for comparison.
Results/Discussion
Prevalence of PCI was 17.4% in the EPIPorto and 15.1% in the NEON-PC cohort (age- and education-adjusted OR = 1.02,95% confidence interval: 0.70,1.50). NP assessment was performed in 65 patients with PCa: 38.5% had normal cognitive function; 7.7% had a light deficit (<1.0 SD of age-corrected norms in ≥ 1 cognitive tasks); and 53.9% had CI.
Conclusions
PCI was as frequent in patients recently diagnosed with PCa as in the general population. Prevalence of CI was lower than in previous reports, which may be explained by differences in the assessment and definition of CI and of the type of cancer.
Funding
POCI-01-0145FEDER-032358;PTDC/SAU-EPI/32358/2017;UIDB/4750/2020; SFRH/BD/119390/2016
Key messages
Patients with prostate cancer and the general population had similar odds of having a score below normative values in the MoCA. Differences in the prevalence of CI between this study and others suggest that the type of cancer may affect patients’ cognitive performance differently, which deserves further confirmation.
Collapse
Affiliation(s)
- N Araujo
- Epidemiology Research Unit, Institute of Public Health, University of Porto, Porto, Portugal
- Laboratory for Integrative and Translational Research in Population Health, Institute of Public Health, University of Porto, Porto, Portugal
| | - A Costa
- Epidemiology Research Unit, Institute of Public Health, University of Porto, Porto, Portugal
- Laboratory for Integrative and Translational Research in Population Health, Institute of Public Health, University of Porto, Porto, Portugal
| | - L Lopes-Conceição
- Epidemiology Research Unit, Institute of Public Health, University of Porto, Porto, Portugal
- Laboratory for Integrative and Translational Research in Population Health, Institute of Public Health, University of Porto, Porto, Portugal
- Research Center, Portuguese Institute of Oncology of Porto, Porto, Portugal
| | - A Ferreira
- Neurology Department, Portuguese Institute of Oncology of Porto, Porto, Portugal
| | - F Carneiro
- Urology Department, Portuguese Institute of Oncology of Porto, Porto, Portugal
| | - J Oliveira
- Urology Department, Portuguese Institute of Oncology of Porto, Porto, Portugal
| | - S Morais
- Epidemiology Research Unit, Institute of Public Health, University of Porto, Porto, Portugal
- Laboratory for Integrative and Translational Research in Population Health, Institute of Public Health, University of Porto, Porto, Portugal
- Public Health and Forensic Sciences, and Medical Education D, Faculty of Medicine of the University of Porto, Porto, Portugal
| | - L Ruano
- Epidemiology Research Unit, Institute of Public Health, University of Porto, Porto, Portugal
- Laboratory for Integrative and Translational Research in Population Health, Institute of Public Health, University of Porto, Porto, Portugal
- Neurology Department, São Sebastião Hospital, Santa-Maria da Feira, Portugal
| | - S Pereira
- Epidemiology Research Unit, Institute of Public Health, University of Porto, Porto, Portugal
- Laboratory for Integrative and Translational Research in Population Health, Institute of Public Health, University of Porto, Porto, Portugal
- Neurology Department, Portuguese Institute of Oncology of Porto, Porto, Portugal
| | - N Lunet
- Epidemiology Research Unit, Institute of Public Health, University of Porto, Porto, Portugal
- Laboratory for Integrative and Translational Research in Population Health, Institute of Public Health, University of Porto, Porto, Portugal
- Public Health and Forensic Sciences, and Medical Education D, Faculty of Medicine of the University of Porto, Porto, Portugal
| |
Collapse
|
43
|
Paixão S, Suzano C, Ferreira A, Figueiredo JP. Gender (in)equality in the labor market: a case study of Environmental Health Officers. Eur J Public Health 2021. [DOI: 10.1093/eurpub/ckab165.616] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
The female gender has been discriminated, as it is considered inferior, in relation to the male. In the health sector, although the proportion of women has increased, the occupational segregation still persist. The mortality rate reduction, is largely due to the unrecognized contribution of women. Segregation manifests itself in a variety of ways, ranging from a limited set of opportunities to wage disparities. It's paradox since, even in “mostly female” jobs, like Environmental Health (EH), the minority of men usually have an “escalator”, reaching leadership quickly. This abstract addresses the gaps in the challenges of gender inequality in EH, since the fact that women are a health driver is been ignored. We seek to know the attitudes and opinions of the Environmental Health Officers (EHO), about: identity centralities; discrimination in society, profession and organization. This study is observational, descriptive, cross-sectional and level of knowledge II. The target population comprises by EHO (women and men). The sample design adopted was non-probabilistic and technical for convenience. The information was collected through a digital questionnaire. On average, men presented a more conservative view, compared to the female, associating women to mother's role and housewives, revealing a certain conservatism. There was, therefore, a prevalence of gender stereotypes. A correlation was found, about the organizational discrimination, since who revelead a minor difference between genders, were also those who presented a lower index of stereotypes. In other words, an organization that provides a life balance, leads its workers to desconstruct social and professional stereotypes. In conclusion, a gender diagnosis is essential to identify asymmetries and to start the change. This study identifies and analyzes inequalities in the EH area. Most of the results found follow the literature and are relevant to define future strategies.
Key messages
Global health organizations are starting to recognize the importance of gender challenges as a way to achieve universal health coverage which facilitates a new narrative. Recent data from the International Labor Organization estimate that gender pay gaps in the health sector are higher compared to other sectors, although women hold a large number of health jobs.
Collapse
Affiliation(s)
- S Paixão
- Environmental Health Department, IPC, Coimbra Health School, Coimbra, Portugal
- Centre of Studies in Geography and Spatial Planning, Coimbra University, Coimbra, Portugal
| | - C Suzano
- Environmental Health Department, IPC, Coimbra Health School, Coimbra, Portugal
| | - A Ferreira
- Environmental Health Department, IPC, Coimbra Health School, Coimbra, Portugal
| | - JP Figueiredo
- Department of Complementary Sciences, IPC, Coimbra Health School, Coimbra, Portugal
| |
Collapse
|
44
|
Araujo N, Costa A, Conceição-Lopes L, Ferreira A, Carneiro F, Pacheco-Figueiredo L, Morais S, Tedim-Cruz V, Pereira S, Lunet N. Androgen deprivation therapy and cognitive decline in the NEON-PC study. Eur J Public Health 2021. [DOI: 10.1093/eurpub/ckab165.258] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Abstract
Background/Objective
Androgen deprivation therapy (ADT) has been associated with cognitive decline, but results have been heterogenous. We describe changes in cognitive performance in patients with prostate cancer (PCa), according to treatment with ADT, during the 1st year after PCa diagnosis.
Methods
Between February 2018 and March 2021, 348 patients with PCa treated at the Instituto Português de Oncologia do Porto were evaluated with the Montreal Cognitive Assessment (MoCA), before treatment and after one year (1y). ADT was used in 183 participants, and 165 were treated without ADT (total prostatectomy, radiotherapy, brachytherapy, active surveillance). Cognitive decline was defined as the decrease in MoCA from baseline to the 1y-evaluation below 1.5SD of the distribution of the MoCA variation in the whole cohort. Participants scoring below age- and education-based normative reference values in MoCA were considered to have probable cognitive impairment (PCI). Multivariate logistic regression was used to estimate age- and education-adjusted OR (aOR) of the association between ADT and cognitive decline/incident PCI.
Results/Discussion
PCI was observed in 12.4% of the patients at baseline. Mean MoCA scores increased from baseline to the 1y-evaluation (22.4 vs. 22.9, p = 0.001), and 51.2% of PCI cases at baseline had normal MoCA scores at 1y. Cognitive decline was most frequent in the ADT group (9.3% vs. 3.6%, p = 0.034), although the aOR was 2.44 (95%CI:0.89-6.71). The 1yr cumulative incidence of PCI was 10.4% (95%CI:6.2%-16.2%) in the ADT-group and 2.8% (95%CI:0.8-%-7.1%) in the non-ADT group [aOR=3.15 (95%CI:0.97-10.25)].
Conclusions
ADT was associated with a decrease in the cognitive performance of PCa patients during the 1st year after diagnosis. The completion of the 1y-evaluation in the whole cohort (n = 600) is needed to confirm these preliminary results.
Funding
POCI-01-0145FEDER-032358;PTDC/SAU-EPI/32358/2017; UIDB/4750/2020;SFRH/BD/119390/2016
Key messages
Half of the cases with cognitive impairment at baseline improved at one-year. Patients treated with ADT seem to be affected by cognitive decline more frequently.
Collapse
Affiliation(s)
- N Araujo
- Epidemiology Research Unit, Institute of Public Health, University of Porto, Porto, Portugal
- Laboratory for Integrative and Translational Research in Pop, Institute of Public Health, University of Porto, Porto, Portugal
| | - A Costa
- Epidemiology Research Unit, Institute of Public Health, University of Porto, Porto, Portugal
- Laboratory for Integrative and Translational Research in Pop, Institute of Public Health, University of Porto, Porto, Portugal
| | - L Conceição-Lopes
- Epidemiology Research Unit, Institute of Public Health, University of Porto, Porto, Portugal
- Laboratory for Integrative and Translational Research in Pop, Institute of Public Health, University of Porto, Porto, Portugal
- Research Center, Portuguese Institute of Oncology of Porto, Porto, Portugal
| | - A Ferreira
- Neurology Department, Portuguese Institute of Oncology of Porto, Porto, Portugal
| | - F Carneiro
- Urology Department, Portuguese Institute of Oncology of Porto, Porto, Portugal
| | | | - S Morais
- Epidemiology Research Unit, Institute of Public Health, University of Porto, Porto, Portugal
- Laboratory for Integrative and Translational Research in Pop, Institute of Public Health, University of Porto, Porto, Portugal
- Public Health and Forensic Sciences, and Medical Education D, Faculty of Medicine of the University of Porto, Porto, Portugal
| | - V Tedim-Cruz
- Epidemiology Research Unit, Institute of Public Health, University of Porto, Porto, Portugal
- Laboratory for Integrative and Translational Research in Pop, Institute of Public Health, University of Porto, Porto, Portugal
- Neurology Department, Pedro Hispano Hospital, Local Health Unit of Matosinhos, Senhora da Hora, Portugal
| | - S Pereira
- Epidemiology Research Unit, Institute of Public Health, University of Porto, Porto, Portugal
- Laboratory for Integrative and Translational Research in Pop, Institute of Public Health, University of Porto, Porto, Portugal
- Neurology Department, Portuguese Institute of Oncology of Porto, Porto, Portugal
| | - N Lunet
- Epidemiology Research Unit, Institute of Public Health, University of Porto, Porto, Portugal
- Laboratory for Integrative and Translational Research in Pop, Institute of Public Health, University of Porto, Porto, Portugal
- Public Health and Forensic Sciences, and Medical Education D, Faculty of Medicine of the University of Porto, Porto, Portugal
| |
Collapse
|
45
|
Costa C, Amador F, Calvao J, Pestana G, Lebreiro A, Pinto R, Proenca T, Carvalho M, Pinho T, Ferreira A, Albuquerque-Roncon R, Adao L, Macedo F. Catheter ablation supported by extracorporeal membrane oxygenation -last resort treatment of arrhythmic storm? Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.0356] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Introduction
Arrhythmic storm (AS) is associated with high mortality, even with best medical care and hemodynamic support. If medical therapeutic failure, electrophysiological mapping and ablation are potential lifesaving therapies. Venoarterial extracorporeal membrane oxygenation (VA-ECMO) provides temporary mechanical circulatory support and can be used as a salvage intervention in patients with cardiogenic shock. Considering the seriousness of AS and the technical complexity involved, catheter ablation supported by VA-ECMO is infrequently performed. We sought to assess the safety and effectiveness of emergent catheter ablation procedures performed in patients on VA-ECMO at our hospital.
Methods
Retrospective study of all ventricular tachycardia (VT) catheter ablation procedures performed with VA-ECMO support at a tertiary centre between 2016 and 2020. Follow-up data was obtained from review of electronical records.
Results
Five patients underwent 6 emergent VT ablation procedures due to AS. The median age was 62 years (range, 52) and 4 patients were men. Three patients had VT at admission, while 2 were admitted with an acute coronary syndrome and developed VT during the hospitalization. Four patients had ischemic heart disease, though only 1 had previous history of VT; the remaining patient presented no structural heart disease. Median left ventricle ejection fraction was 11% (range 30).
All patients had incomplete response to amiodarone, lidocaine or overdrive pacing, before being proposed to catheter ablation. Four patients were on ECMO support before ablation, while 1 was cannulated during the procedure due to hemodynamic instability. Ablation was performed using a retrograde approach in 3 patients, and combined retrograde and transeptal access in 2; one patient had epicardial ablation after unsuccessful endovascular approach. Three patients had left ventricle substrate ablation and the remaining 2 of the right ventricle. No major complications were seen directly related to the procedures.
The median length of stay in intensive care unit was 22 days (range 41 days). Weaning of VA-ECMO was accomplished in all patients. Two patient died during the same hospitalization (one due to uncontrolled arrhythmic events). At a median 23 months (range 31) of follow-up of the surviving patients, two had recurrence of VT but no one had return of AS.
Conclusion
In our sample VT ablation on VA-ECMO support was a safe procedure, with no immediate complications. However, as reported in the literature, a high mortality rate was observed both in-hospital and during follow-up, mostly related to advanced structural heart disease. Also, considerable VT recurrence rates were seen, but with no re-hospitalization. Our experience shows that catheter ablation is a life-saving procedure in otherwise uncontrollable AS and allowed absolute success in weaning VA-ECMO.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- C Costa
- Sao Joao Hospital, Porto, Portugal
| | - F Amador
- Sao Joao Hospital, Porto, Portugal
| | - J Calvao
- Sao Joao Hospital, Porto, Portugal
| | | | | | - R Pinto
- Sao Joao Hospital, Porto, Portugal
| | | | | | - T Pinho
- Sao Joao Hospital, Porto, Portugal
| | | | | | - L Adao
- Sao Joao Hospital, Porto, Portugal
| | - F Macedo
- Sao Joao Hospital, Porto, Portugal
| |
Collapse
|
46
|
Lopes P, Albuquerque F, Freitas P, Presume J, Rocha B, Cunha G, Strong C, Tralhao A, Trabulo M, Ferreira J, Ventosa A, Aguiar C, Mendes M, Ferreira A. Validation of a novel framework defining the acceptable standard of care for heart failure with reduced ejection fraction. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.0914] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Abstract
Background
In heart failure with reduced ejection fraction (HFrEF), uptitration of neurohormonal antagonists to trial-proven doses shown to reduce mortality is challenging and seldomly achieved in clinical practice. A major reason for underdosing of these agents is the lack of a clear description of what constitutes an acceptable standard of care in HFrEF. To address this limitation, a novel framework for describing the physician adherence to evidence-based treatment was recently proposed. The aim of our study was to evaluate and validate the proposed framework in a real-world population of patients with HFrEF.
Methods
A cohort of patients with HFrEF, defined as left ventricular ejection fraction (LVEF) <40%, under treatment with neurohormonal antagonists for at least 3 months were retrospectively identified at a tertiary hospital's Heart Failure Clinic. Demographic, clinical, echocardiographic and treatment data were assessed. Patients were divided in three strata for each neurohormonal antagonist, according to the proposed framework: Status I – patients receiving target doses or the highest tolerated dose; Status II – use of subtarget doses for reasons unrelated to clinically important intolerance; and Status III – not receiving the drug at any dose. The prognostic value of each strata was assessed for all-cause mortality.
Results
A total of 408 patients (mean age 68±12 years, 78% male, 63% ischemic etiology) were included. The median LVEF was 31% (IQR 25–36) and most patients were in NYHA class II or III [210 (51.5%) and 163 (40%), respectively]. Medical therapy is described in Table 1. During a median follow-up of 3.3 years (IQR 1.4–5.6), 210 patients died. On univariable analysis, achieving Status I of beta-blocker (BB) therapy (HR: 0.50; 95% CI: 0.32–0.81; P=0.004) or ACEi/ARB (HR: 0.56; 95% CI: 0.36–0.86; P=0.012) was associated with reduced all-cause mortality. The mortality of patients in Status II of BB or ACEi/ARB was similar to the mortality of those not receiving the drug (HR for BB: 0.90; 95% CI: 0.53–1.52; P=0.69 and HR for ACEi/ARB: 0.71; 95% CI: 0.42–1.18; P=0.182) – figure 1. Achieving Status I of BB remained independently associated with reduced mortality after adjustment for several clinical and echocardiographic confounders (n=13) (adjusted HR: 0.59; 95% CI: 0.35–0.98; P=0.041).
Conclusions
In this real-world population of patients with HFrEF, the vast majority of patients were in Status I of BB and ACEi/ARB therapy. Achieving Status I of BB therapy seems to be associated with reduced mortality, even after adjustment for several markers of disease severity, highlighting the need for uptitration of medical therapy to maximal tolerated doses according to trial-proven regimens.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- P Lopes
- Hospital Santa Cruz, Carnaxide, Portugal
| | | | - P Freitas
- Hospital Santa Cruz, Carnaxide, Portugal
| | - J Presume
- Hospital Santa Cruz, Carnaxide, Portugal
| | - B Rocha
- Hospital Santa Cruz, Carnaxide, Portugal
| | - G Cunha
- Hospital Santa Cruz, Carnaxide, Portugal
| | - C Strong
- Hospital Santa Cruz, Carnaxide, Portugal
| | - A Tralhao
- Hospital Santa Cruz, Carnaxide, Portugal
| | - M Trabulo
- Hospital Santa Cruz, Carnaxide, Portugal
| | - J Ferreira
- Hospital Santa Cruz, Carnaxide, Portugal
| | - A Ventosa
- Hospital Santa Cruz, Carnaxide, Portugal
| | - C Aguiar
- Hospital Santa Cruz, Carnaxide, Portugal
| | - M Mendes
- Hospital Santa Cruz, Carnaxide, Portugal
| | - A Ferreira
- Hospital Santa Cruz, Carnaxide, Portugal
| |
Collapse
|
47
|
Albuquerque F, De Araujo Goncalves P, Ferreira A, Lopes P, Dores H, Marques H, Freitas P, Goncalves M, Cardim N. Anomalous origin of the right coronary artery with interarterial course: red flag or innocent bystander? Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.1851] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Aims
Anomalous origin of the right coronary artery from the opposite sinus (right-ACAOS) with interarterial course (IAC) has been associated with increased risk of sudden cardiac death (SCD). Widespread use of coronary computed tomography angiography (CCTA) has led to increasing recognition of this condition, even among healthy individuals. Our study sought to examine the prevalence, anatomical characteristics and outcomes of right-ACAOS with IAC in patients undergoing CCTA for suspected coronary artery disease (CAD).
Methods and results
We conducted a retrospective analysis of consecutive patients referred for CCTA at one tertiary hospital from January 2012 to December 2020. Right-ACAOS with IAC patients were analyzed for cardiac symptoms and long-term occurrence of first MACE (SCD, non-fatal myocardial infarction (MI) or revascularization of the anomalous vessel). CCTAs were reviewed for anatomical high-risk features and concomitant CAD. Among 10928 patients referred for CCTA, 28 patients with right-ACAOS with IAC were identified. Mean age was 55±17 years, 64% were male and 11 (39.3%) presented with stable cardiac symptoms. Most patients had at least one high risk anatomical feature. During follow-up, there were no CV deaths or aborted SCD episodes and only 1 patient underwent surgical revascularization of the anomalous vessel.
Conclusion
Right-ACAOS with IAC is an uncommon finding (prevalence of 0.26%). In a contemporary population of predominantly asymptomatic patients who survived this condition well into adulthood, most patients were managed conservatively with a low event rate. Additional studies are needed to support medical follow-up as the preferred option in this setting.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
| | | | | | - P Lopes
- Hospital da Luz, Lisboa, Portugal
| | - H Dores
- Hospital da Luz, Lisboa, Portugal
| | | | | | | | - N Cardim
- Hospital da Luz, Lisboa, Portugal
| |
Collapse
|
48
|
Lopes P, Presume J, Goncalves PA, Albuquerque F, Freitas P, Guerreiro S, Abecasis J, Santos AC, Saraiva C, Mendes M, Marques H, Ferreira A. Incorporating coronary calcification into pretest assessment of the likelihood of coronary artery disease: validation and recalibration of a new diagnostic tool. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.0205] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
A new clinical tool was recently proposed to improve the estimation of pre-test probability of obstructive coronary artery disease (CAD) by incorporating coronary artery calcium score (CACS) with clinical risk factors. This new model (Clinical+CACS) showed improved prediction when compared to the method recommended by the 2019 ESC guidelines on chronic coronary syndromes, but was never tested or adjusted for use in our population. The aim of this study was to assess the performance of this new method in a Portuguese cohort of symptomatic patients referred for coronary computed tomography angiography (CCTA), and to recalibrate it if necessary.
Methods
We conducted a two-center cross-sectional study assessing symptomatic patients who underwent CCTA for suspected CAD. Key exclusion criteria were age <30 years, known CAD, suspected acute coronary syndrome, or symptoms other than chest pain or dyspnea. Obstructive CAD was defined as any luminal stenosis ≥50% on CCTA. The Clinical+CACS prediction model was assessed for discrimination and calibration. A logistical recalibration of the model was conducted in a random sample of 50% of the patients and subsequently validated in the other half.
Results
A total of 1910 patients (mean age 60±11 years, 60% women) were included in the analysis. Symptom characteristics were: 39% non-anginal chest pain, 30% atypical angina, 19% dyspnea and 12% typical angina. The observed prevalence of obstructive CAD was 12.9% (n=247). Patients with obstructive CAD were more often male, were significantly older, had higher prevalence of typical angina and cardiovascular risk factors, and higher CACS values. The new Clinical+CACS tool showed greater discriminative power than the ESC 2019 prediction model, with a C-statistic of 0.83 (CI 95% 0.81–0.86) versus 0.67 (CI 95% 0.64–0.71), respectively (p-value for comparison <0.001). Before recalibration, the Clinical+CACS model underestimated the likelihood of CAD in our population across all quartiles of pretest probability (mean relative underestimation of 49%), which was subsequently corrected by the recalibration procedure - Figure.
Conclusions
In a Portuguese cohort of symptomatic patients undergoing CCTA for suspected CAD, the new Clinical+CACS model showed better discrimination power than the 2019 ESC method. The underestimation of the Clinical+CACS model was corrected by recalibrating it for our population. This new tool might prove useful for guiding decisions on the need for further testing.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- P Lopes
- Hospital Santa Cruz, Carnaxide, Portugal
| | - J Presume
- Hospital Santa Cruz, Carnaxide, Portugal
| | - P A Goncalves
- UNICA – Cardiovascular CT and MR Unit, Hospital da Luz, Lisbon, Portugal
| | | | - P Freitas
- Hospital Santa Cruz, Carnaxide, Portugal
| | | | - J Abecasis
- Hospital Santa Cruz, Carnaxide, Portugal
| | - A C Santos
- Hospital Santa Cruz, Carnaxide, Portugal
| | - C Saraiva
- Hospital Santa Cruz, Carnaxide, Portugal
| | - M Mendes
- Hospital Santa Cruz, Carnaxide, Portugal
| | - H Marques
- UNICA – Cardiovascular CT and MR Unit, Hospital da Luz, Lisbon, Portugal
| | - A Ferreira
- Hospital Santa Cruz, Carnaxide, Portugal
| |
Collapse
|
49
|
Lopes P, Freitas P, Ferreira A, Sousa JA, Rocha B, Cunha G, Cavaco D, Abecasis J, Carmo P, Saraiva C, Morgado F, Chotalal D, Feliciano S, Mendes M, Adragao P. The gray zone of myocardial fibrosis is a better predictor of ventricular arrhythmias than total myocardial fibrosis in patients with previous myocardial infarction. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.0216] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Current sudden cardiac death (SCD) risk stratification relies heavily on the assessment of left ventricular ejection fraction (LVEF), but markers that could refine risk assessment are needed. Total fibrosis mass (TFM) and “gray zone” of myocardial fibrosis (GZF) on late gadolinium enhancement cardiac magnetic resonance (LGE-CMR) have been proposed as potential arrhythmogenic substrates. The aim of our study was to determine whether TFM and GZF can predict the occurrence of ventricular arrhythmias in patients with previous myocardial infarction.
Methods
We performed a single centre retrospective study enrolling all consecutive patients with previous myocardial infarction undergoing LGE-CMR before implantable cardioverter-defibrillator (ICD) implantation for primary or secondary prevention. TFM and GZF were defined as myocardial tissue with signal-intensities >6 SD and 2–6 SD above the mean of reference myocardium, respectively. The primary endpoint was a composite of sudden arrhythmic death, appropriate ICD shock, ventricular fibrillation (VF), or sustained ventricular tachycardia (VT) as detected by the device.
Results
A total of 55 patients (mean age 62±12 years, 87% male, mean LVEF 30% ± 8%) were included. During a mean follow-up period of 34±15 months, 10 patients reached the primary endpoint (8 appropriate ICD shock, 2 sustained VT or VF). Patients who attained the primary endpoint had similar TFM (28.6g ± 14.5 vs. 23.1g ± 14.5; P=0.283) but larger GZF (25.3g ± 11.0 vs 15.6g ± 7.3; P=0.001). After adjustment for LVEF, GZF remained independently associated with the composite arrhythmic endpoint (adjusted hazard ratio [aHR]: 1.10; 95% CI: 1.03–1.17; P=0.005), whereas TFM did not (aHR: 1.02; 95% CI: 0.98–1.06; P=0.394). Decision tree analysis identified 16.4g of GZF as the best cut-off to predict life-threatening arrhythmic events. The primary endpoint occurred in 9 out of the 22 patients (41%) with GZF >16.4g, but in only 1 of the 33 patients (3%) with GZF ≤16.4g – Figure.
Conclusions
The extent of GZF seems to be a better predictor of ventricular arrhythmias than TFM. This LGE-CMR parameter may be useful to identify a subgroup of patients with previous myocardial infarction at an increased risk of life-threatening arrhythmic events.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- P Lopes
- Hospital Santa Cruz, Carnaxide, Portugal
| | - P Freitas
- Hospital Santa Cruz, Carnaxide, Portugal
| | - A Ferreira
- Hospital Santa Cruz, Carnaxide, Portugal
| | - J A Sousa
- Hospital Santa Cruz, Carnaxide, Portugal
| | - B Rocha
- Hospital Santa Cruz, Carnaxide, Portugal
| | - G Cunha
- Hospital Santa Cruz, Carnaxide, Portugal
| | - D Cavaco
- Hospital Santa Cruz, Carnaxide, Portugal
| | - J Abecasis
- Hospital Santa Cruz, Carnaxide, Portugal
| | - P Carmo
- Hospital Santa Cruz, Carnaxide, Portugal
| | - C Saraiva
- Hospital Santa Cruz, Carnaxide, Portugal
| | - F Morgado
- Hospital Santa Cruz, Carnaxide, Portugal
| | - D Chotalal
- Hospital Santa Cruz, Carnaxide, Portugal
| | | | - M Mendes
- Hospital Santa Cruz, Carnaxide, Portugal
| | - P Adragao
- Hospital Santa Cruz, Carnaxide, Portugal
| |
Collapse
|
50
|
Rocha B, Cunha G, Sousa J, Maltes S, Freitas P, Brizido C, Strong C, Ribeiras R, Andrade M, Aguiar C, Ferreira A, Mendes M. The odyssey to dethrone LV ejection fraction continues: the prognostic value of LV global function index in heart failure. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.0853] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Left Ventricular (LV) Global Function index (LVGFi) is a parameter that combines data from global systolic performance and volumetric anatomical information, measurable by non-contrast Cardiac Magnetic Resonance (CMR). We aimed to evaluate whether LVGFi predicts major cardiovascular outcomes and outperforms LV ejection fraction (LVEF) in Heart Failure (HF).
Methods
We conducted a retrospective single-centre study of consecutive patients with HF who were referred to and had a LVEF <50% at CMR. Other than inadequate images for endocardial or epicardial border delineation, there were no exclusion criteria. LVEF was determined by 3D measurement. LVGFi was calculated as the LV stroke volume to the LV global volume ratio (Figure 1). The primary endpoint was a composite of time to all-cause death or HF hospitalization.
Results
The cohort was comprised of 433 HF patients (mean age 64±12 years, 74.1% male, ischaemic HF 53.1%, NYHA I-II 83.9%) with a mean LVEF of 33.5±10.0% and LVGFi of 22.8±7.4%. Over a median follow-up of 27 (17–37) months, 85 (19.6%) met the primary endpoint and 42 (9.7%) died. Patients with an event of the primary endpoint had markers of more severe HF, as noted by a reduced functional capacity (NYHA I-II: 63.5 vs. 89.0%; p<0.001) and increased natriuretic peptides [NT-proBNP: 2664 (1022–27242) vs. 791 (337–7258); p<0.001). Likewise, CMR showed higher LV volumes (e.g., LV end-diastolic volume index: 137±50 vs. 120±43mL/m2; p=0.001) and reduced LV performance indices, namely LVEF (29.2±10.6 vs 34.5±9.6%; p<0.001) and LVGFi (19.8±7.4 vs 23.6±7.3%; p<0.001). Both LVEF and LVGFi independently predicted the primary endpoint in multivariate analysis (separately imputed into a model adjusted for NYHA, NT-proBNP and creatinine). The LVEF model was more powerful than that of LVGFi. Similarly, LVGFi did not provide incremental prognostic information over LVEF in c-statistics analysis (0.653 vs. 0.622; p=0.645) (Figure 2).
Conclusion
While LVGFi independently predicted major outcomes in patients with HF and LVEF <50%, it did not surpass LVEF. Our findings contrast to those demonstrating LVGFi as a powerful variable that outperforms LVEF in hypertrophic cardiomyopathy, cardiac amyloidosis, and healthy subjects at risk of developing structural heart disease. We hypothesize that LVGFi might be primarily useful in the prognostic stratification of patients with preserved LVEF.
Funding Acknowledgement
Type of funding sources: None. Figure 1Figure 2
Collapse
Affiliation(s)
- B Rocha
- Hospital de Santa Cruz, Lisbon, Portugal
| | - G Cunha
- Hospital de Santa Cruz, Lisbon, Portugal
| | - J.A Sousa
- Hospital de Santa Cruz, Lisbon, Portugal
| | - S Maltes
- Hospital de Santa Cruz, Lisbon, Portugal
| | - P Freitas
- Hospital de Santa Cruz, Lisbon, Portugal
| | - C Brizido
- Hospital de Santa Cruz, Lisbon, Portugal
| | - C Strong
- Hospital de Santa Cruz, Lisbon, Portugal
| | - R Ribeiras
- Hospital de Santa Cruz, Lisbon, Portugal
| | | | - C Aguiar
- Hospital de Santa Cruz, Lisbon, Portugal
| | - A Ferreira
- Hospital de Santa Cruz, Lisbon, Portugal
| | - M Mendes
- Hospital de Santa Cruz, Lisbon, Portugal
| |
Collapse
|